US20150359563A1 - Method and apparatus for accessing the left atrial appendage - Google Patents
Method and apparatus for accessing the left atrial appendage Download PDFInfo
- Publication number
- US20150359563A1 US20150359563A1 US14/834,499 US201514834499A US2015359563A1 US 20150359563 A1 US20150359563 A1 US 20150359563A1 US 201514834499 A US201514834499 A US 201514834499A US 2015359563 A1 US2015359563 A1 US 2015359563A1
- Authority
- US
- United States
- Prior art keywords
- needle
- sheath
- dilator
- fossa ovalis
- curved section
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000005248 left atrial appendage Anatomy 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title abstract description 26
- 210000005246 left atrium Anatomy 0.000 claims abstract description 46
- 210000005245 right atrium Anatomy 0.000 claims description 23
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 9
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 9
- 230000035515 penetration Effects 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 230000001154 acute effect Effects 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 210000005247 right atrial appendage Anatomy 0.000 claims 1
- 238000002604 ultrasonography Methods 0.000 claims 1
- 230000000916 dilatatory effect Effects 0.000 abstract 1
- 238000005520 cutting process Methods 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 239000000463 material Substances 0.000 description 15
- 230000001746 atrial effect Effects 0.000 description 11
- 239000000835 fiber Substances 0.000 description 11
- 230000007704 transition Effects 0.000 description 10
- 230000005540 biological transmission Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 210000002620 vena cava superior Anatomy 0.000 description 9
- 210000005240 left ventricle Anatomy 0.000 description 8
- 230000035479 physiological effects, processes and functions Effects 0.000 description 7
- 238000013459 approach Methods 0.000 description 6
- 238000004891 communication Methods 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 210000004115 mitral valve Anatomy 0.000 description 5
- 210000001765 aortic valve Anatomy 0.000 description 4
- 210000003191 femoral vein Anatomy 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000012800 visualization Methods 0.000 description 4
- 229920002614 Polyether block amide Polymers 0.000 description 3
- 238000002594 fluoroscopy Methods 0.000 description 3
- 229920001903 high density polyethylene Polymers 0.000 description 3
- 239000004700 high-density polyethylene Substances 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 210000001631 vena cava inferior Anatomy 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 210000003157 atrial septum Anatomy 0.000 description 2
- 230000004323 axial length Effects 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 210000004971 interatrial septum Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000003492 pulmonary vein Anatomy 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010014498 Embolic stroke Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 208000020128 Mitral stenosis Diseases 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 206010002906 aortic stenosis Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000013153 catheter ablation Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000019589 hardness Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000009998 heat setting Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 208000006887 mitral valve stenosis Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000591 tricuspid valve Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
- A61B17/3423—Access ports, e.g. toroid shape introducers for instruments or hands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3203—Fluid jet cutting instruments
- A61B17/32037—Fluid jet cutting instruments for removing obstructions from inner organs or blood vessels, e.g. for atherectomy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320725—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/32075—Pullback cutting; combined forward and pullback cutting, e.g. with cutters at both sides of the plaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3478—Endoscopic needles, e.g. for infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/320016—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00367—Details of actuation of instruments, e.g. relations between pushing buttons, or the like, and activation of the tool, working tip, or the like
- A61B2017/00398—Details of actuation of instruments, e.g. relations between pushing buttons, or the like, and activation of the tool, working tip, or the like using powered actuators, e.g. stepper motors, solenoids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
- A61B2017/00783—Valvuloplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
- A61B17/3423—Access ports, e.g. toroid shape introducers for instruments or hands
- A61B2017/3425—Access ports, e.g. toroid shape introducers for instruments or hands for internal organs, e.g. heart ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
- A61B5/0086—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters using infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
Definitions
- the present invention relates to transseptal access systems for accessing the left atrium from the right atrium such as by crossing the fossa ovalis.
- the typical human heart includes a right ventricle, a right atrium, left ventricle and left atrium.
- the right atrium is in fluid communication with the superior vena cava and the inferior vena cava.
- the tricuspid valve separates the right atrium from the right ventricle.
- On the inner wall of the right atrium where it is separated from the left atrium is a thin walled, recessed portion, the fossa ovalis.
- the fossa ovalis is open (patent foramen), permitting fetal blood to flow between the right and left atria, bypassing the fetal lungs in favor of the placental blood flow. In most individuals, this opening closes after birth. In as many as about 20 percent of adults an opening (the patent foramen) still remains in place of the fossa ovalis between the right and left atria.
- a wide variety of diagnostic and therapeutic procedures have been developed in which a catheter is transluminally advanced into various chambers and across valves of the heart.
- the most difficult chamber of the heart to access with a catheter is the left atrium. Access to the left atrium through the pulmonary artery is not possible. Approaches from the left ventricle are difficult, may cause arrhythmias and may present difficulty in obtaining stable catheter positioning. Accordingly, the presently preferred method of accessing the left atrium is through a transseptal approach, achieved by catheterization of the right atrium with subsequent penetration of the interatrial septum.
- the reduced wall thickness and location of the fossa ovalis makes it a useful access point for a transseptal access puncture.
- left atrial access can be either diagnostic or therapeutic.
- One diagnostic use is pressure measurement in the left atrium.
- left atrial access allows a determination of the pressure difference between the left atrium and left ventricle.
- Left atrial access also allows entry into the left ventricle through the mitral valve. This is desirable when an artificial aortic valve is in place.
- Diagnostic measurement of the left ventricular pressures are, therefore, desirable to allow evaluation of mechanical artificial aortic valves post-replacement. It may be unsafe to cross these mechanical artificial valves retrograde from the aorta; therefore, access to the left ventricle by the antegrade route using a transseptal puncture is the preferred approach. Once a catheter has been placed in the left atrium using the transseptal approach, access to the left ventricle can be gained by advancing catheters across the mitral valve.
- diagnostic indications exist for left atrial pressure measurements in addition to evaluating the functionality of artificial mitral valves.
- Other diagnostic indications for accessing the left ventricle via the antegrade transseptal approach include aortic stenosis, when a cardiologist is unable to pass a catheter retrograde into the left ventricle, and some disease states where the antegrade approach is considered preferable, such as subaortic obstruction.
- the therapeutic objectives of left atrial access are primarily two-fold.
- the first is mitral valvuloplasty which represents an alternative to surgical procedures to relieve obstruction of the mitral valve.
- the second therapeutic objective is for electrophysiological intervention in the left atrium.
- Catheter ablation involves the placement of energy (typically RF) through a catheter, into various locations of the heart to eradicate inappropriate electrical pathways affecting the heart function. When these locations are in the left atrium, the catheter through which the radio frequency generator is placed typically is itself placed with transseptal catheterization. More recently, therapeutic treatment of the left atrial appendage (LAA) to reduce the risk of embolic stroke has also been proposed.
- LAA left atrial appendage
- a transseptal access sheath comprising; a first curved section, and a second curved section; the first curved section having an outer edge that defines a first proximal edge point, and a first distal edge point, wherein the intersection between a tangent drawn to the first curved section at the first proximal edge point and a tangent drawn to the first curved section at the first distal edge point, define a first angle and a first plane; the second curved section having an outer edge that defines a second proximal edge point, and a second distal edge point; wherein the intersection between a tangent drawn to the second curved section at the second proximal edge point and a tangent drawn to the second curved section at the second distal edge point, define a second angle and a second plane; wherein the first angle is within the range of about 60 to about 120 degrees; wherein the second angle is within the range of about 0 and about 180 degrees, more
- a transseptal access sheath comprising; a first curved section, and a second curved section; wherein the first curved section is shaped to abut the interior wall of the right atrium substantially opposite the fossa ovalis while directing the distal tip toward the fossa ovalis; and, wherein the second curved section is shaped to facilitate location and access of a desired region of the LAA.
- a transseptal access system comprising a sheath, a dilator and a needle; wherein the sheath comprises; a first curved section, and a second curved section; the first curved section having an outer edge that defines a first proximal edge point, and a first distal edge point, wherein the intersection between a tangent drawn to the first curved section at the first proximal edge point and a tangent drawn to the first curved section at the first distal edge point, define a first angle and a first plane; the second curved section having an outer edge that defines a second proximal edge point, and a second distal edge point wherein the intersection between a tangent drawn to the second curved section at the second proximal edge point and a tangent drawn to the second curved section at the second distal edge point, define a second angle and a second plane; wherein the first angle is within the range of about 90 degrees; wherein
- FIG. 1 is a side elevational schematic view of a transseptal access system in accordance with the present invention.
- FIG. 2 is a cross-sectional view taken along the line 2 - 2 in FIG. 1 .
- FIG. 3 is an enlarged perspective view of the distal end of the transseptal access system of FIG. 1 .
- FIG. 4 is a schematic cross-sectional view of a portion of the heart, showing a transseptal access catheter of the present invention within the right atrium.
- FIG. 5 is a cross-sectional view as in FIG. 4 , with the guidewire positioned in the superior vena cava.
- FIG. 6 is a cross-sectional view as in FIG. 4 , with the transseptal access catheter positioned against the wall of the superior vena cava.
- FIG. 7 is a cross-sectional view as in FIG. 4 , with the access catheter positioned against the fossa ovalis.
- FIG. 8 is a cross-sectional view as in FIG. 4 , showing tissue distention or “tenting” as the needle punctures the fossa ovalis.
- FIG. 9 is a cross-sectional view as in FIG. 8 , showing tissue distention as the dilator is advanced through the fossa ovalis.
- FIG. 10 is a cross-sectional view as in FIG. 9 , illustrating the sheath, which has been advanced over the dilator and through the septum.
- FIG. 11 is a cross-sectional view as in FIG. 10 , with the dilator removed, leaving the sheath in place across the fossa ovalis.
- FIGS. 12 and 13 are perspective schematic views of a transseptal access sheath in accordance with the present invention.
- FIGS. 14A-C are perspective views of vents in the transseptal access sheath.
- FIGS. 15A-C are side views of a dilator in accordance with one embodiment of the present invention.
- FIGS. 16A-C are side views of various dilators in accordance with further embodiments of the present invention.
- FIGS. 17A-C are side views of the jacket in accordance with one embodiment of the present invention.
- FIG. 18 is a side view of the transseptal access sheath in accordance with one embodiment of the present invention.
- FIG. 19 is a side view of the transseptal access sheath in accordance with one embodiment of the present invention. %
- FIGS. 20A and 20B are side views of the needle in accordance with one embodiment of the present invention.
- FIG. 21 is a side view of the needle in accordance with one embodiment of the present invention.
- FIGS. 22A-22H are side views of various needles in accordance with further embodiments of the present invention.
- Dilator 20 in accordance with the present invention.
- Dilator 20 has a proximal end 22 , a distal end 24 and an elongate flexible tubular body 26 .
- the overall length of the dilator 20 depends upon the percutaneous access point and the desired application. For example, lengths in the area of from about 80 cm to about 100 cm are typical for use in percutaneous transluminal access at the femoral vein for locating and puncturing a site on the atrial septum in the heart.
- Tubular body 26 may be manufactured in accordance with any of a variety of known techniques, for manufacturing catheters adapted to reach the coronary arteries or chambers of the heart.
- tubular body 26 may be manufactured as an extrusion of appropriate biocompatible polymeric materials such as high density polyethylene, polytetrafluoroethylene (PTFE), nylons, and a variety of others which are known in the art.
- Blended materials may also be used, such as HDPE (e.g., HDPE/LDPE ratios such as 50%:50%, 60%:40% and others) with from about 5% to about 25%, and, in one embodiment, about 20% BaSO.sub.4 for lubricity and radiopacity.
- tubular body 26 may comprise a spring coil, solid walled hypodermic needle tubing (e.g., stainless steel, NiTi alloys) or braided reinforced wall as is understood in the catheter and guidewire arts.
- solid walled hypodermic needle tubing e.g., stainless steel, NiTi alloys
- braided reinforced wall as is understood in the catheter and guidewire arts.
- the tubular body 26 is provided with an approximately circular cross sectional configuration having an outside diameter within the range of from about 0.020 inches to about 0.200 inches. In accordance with one embodiment of the invention, the tubular body 26 has an outside diameter of about 0.160 inches throughout its length. Other lengths and diameters may be readily utilized, depending upon the desired profile and performance characteristics.
- the proximal end 22 is provided with a manifold 28 , having one or more access ports as in known in the art.
- manifold 28 is provided with a core wire port 32 which may also or alternatively function as a guidewire port in an over the wire embodiment.
- An injection port 30 may also be provided, for injecting a contrast media, such as to confirm that the distal end 24 has traversed the intraatrial septum. Additional access ports may be provided as needed, depending upon the functional capabilities of the catheter.
- Manifold 28 may be injection molded from any of a variety of medical grade plastics or formed in accordance with other techniques known in the art.
- the proximal end 22 is also provided with a communication line 34 such as a fiber optic bundle 35 in accordance with one aspect of the present invention.
- fiber optic bundle or signal transmitting line 35 communicates with a signal (e.g. sound, light, ultrasonic or other vibration, etc.) generator and detector 37 .
- the detector 37 enables the catheter to distinguish among solid tissue or a thick membrane, a thin membrane such as at the fossa ovalis, and right atrial or left atrial chamber blood beyond the distal end 24 of dilator 20 as will be discussed.
- the flexible body 26 is provided with a preset bend 25 , for assisting in biasing the distal end 24 against the intraatrial septum as is understood in the art.
- Bend 25 preferably has a radius within the range of from about 0.5 cm to about 5 cm and, in one embodiment, about 2.5 cm. Bend 25 is centered on a point which is within the range of from about 1 cm to about 10 cm proximally from distal end 24 . In one embodiment, the bend 25 is centered at approximately 6 cm proximally from distal end 24 .
- the bend 25 is defined by a proximal transition where it meets the substantially linear proximal portion of the dilator 20 , and a distal transition where it meets the substantially linear distal portion of the dilator 20 .
- the angular deflection of the bend 25 is generally within the range of from about 30.degree. to about 80.degree. and, in one embodiment, is about 50.degree.
- Bend 25 may be provided in accordance with any of a variety of techniques.
- the tubular body 26 which includes a hypotube or other metal tubing
- the tubular body 26 may be bent such as around a forming mandrel in excess of the elastic limit of the hypotube.
- an injection molded catheter body may be heat set in a predetermined bend, such as with removable flexible mandrels extending through any interior lumen to maintain patency of the lumen around the bend.
- Other techniques will be known to those of skill in the art.
- the bend 25 may be formed during or after placement of the catheter in the heart.
- one or more axially moveable pull wires may extend throughout the length of the catheter. Proximal traction on a pull wire which is secured at the distal end of the catheter will cause a lateral defection of the catheter.
- distal end 24 is provided with at least one signal transmitting surface 47 and at least one signal receiving surface 49 .
- Transmitting surface 47 is adapted to transmit a signal from the distal end 24 of dilator 20 and generally in the distal direction with respect to the dilator.
- Receiving surface 49 is adapted for receiving a reflected return signal traveling in a generally proximal direction with respect to the distal end 24 of dilator 20 .
- the transmitting surface 47 comprises the distal end of a fiber optic or fiber optic bundle, or a transparent window positioned at the distal end of a fiber optic or fiber optic bundle.
- the receiving surface 49 comprises a distal end of a receiving fiber optic or a transparent window positioned distally of the receiving fiber optic.
- two transmitting surfaces 47 and two receiving surfaces 49 are provided each communicating with the spectrometer 37 via a unique communication line 34 .
- Transmission and reception of, for example, visible light can alternatively be accomplished though a single transparent window, and embodiments in which the transmission and reception signals are propagated through the same fiber optic or through closely adjacent fiber optics are also contemplated. Propagation of transmission and reception signals through the same fiber optic can be accomplished such as by the provision of a coupler at the proximal end to split the transmission and reception signals for processing at detector 37 as will be understood in, among others, the blood oximetry detector arts. Alternatively, one or more separate transmit surfaces 47 and receiving surfaces 49 may be provided, and anywhere within the range of from about 1 to about 12 of each transmit surface 47 and receiving surface 49 may be provided as desired.
- Signal transmitting bundle 35 thus provides communication between the transmit surface 47 and receiving surface 49 , and a detector 37 such as a spectrometer which remains outside of the patient.
- a detector 37 such as a spectrometer which remains outside of the patient.
- transmitter/detector 37 is able to transmit multiple wavelengths of light, which propagate beyond the transmit surface 47 and into a target beyond the distal end 24 of the dilator 20 . Some of the transmitted light is absorbed in the target, while other transmitted light is reflected back and received at receiving surface 49 . The reflected light is thereafter propagated to the light detector 37 for processing.
- the present inventors have determined that the light detector 37 in combination with the dilator of the present invention can identify when the distal end 24 of the dilator 20 is positioned against the fossa ovalis of the intraatrial septum, as opposed to other portions of the septum or muscle wall, due to the unique characteristics of light observed at the fossa ovalis.
- reflected light at the fossa ovalis will exhibit unique characteristics imparted by (1) light reflected at the surface of or within the fossa ovalis, (2) light reflected through the fossa ovalis by blood in the left atrium, or (3) a combination of the foregoing.
- the ability of an optical detector to locate the fossa based upon light propagated through the fossa is based upon several circumstances.
- the blood in the right atrium is relatively poorly oxygenated, and therefore more blue than red.
- the left atrium contains well oxygenated blood which tends to be relatively red.
- the fossa is thin enough to allow light to be transmitted across the fossa and into and from the left atrium while the fossa locator is still on the right atrial side.
- the septum contains oxygenated blood and therefore has a certain level of red transmission.
- the fossa is a thin translucent membrane which is almost yellow. Non-oxygenated blood within the right atrium is relatively blue, while oxygenated blood within the left atrium is red. Location of the fossa may thus alternatively be accomplished by identifying the presence of a translucent, near yellow membrane.
- the use of multiple wavelengths, transmission, and detectors will allow assessment of both the near yellow color of the fossa, as well as the red color identified through the fossa as will be apparent to those of skill in the art in view of the disclosure herein.
- the method of the present invention may additionally be accomplished by providing a light source within the left atrium.
- the left atrium light source may be provided on any of a variety of left atrium access catheters, as will be apparent to those of skill in the art. Light generated in the left atrium, will be detectable in the right atrium either exclusively at the fossa, or with a greatest intensity appearing at the fossa.
- the left atrium dilator 20 need only be provided with light detector optics and electronics, to identify the fossa based upon the characteristics of light received from the right atrium light source.
- the dilator 20 is additionally provided with a tissue piercing structure 42 such as a needle 44 .
- Needle 44 preferably comprises a tubular structure such as a stainless steel hypotube having a sharpened distal end 50 .
- the sharpened distal end 50 of needle 44 is axially moveable advanceable through an aperture 45 in the distal end 24 of the tubular body 26 .
- the needle 44 has an axial length of from about 1 cm to about 5 cm, an inside diameter of about 0.022 inches and an outside diameter of about 0.032 inches. Any of a variety of other dimensions for needle 44 may also be used depending upon the desired performance and overall catheter dimensions. Needle 44 is connected to the distal end 40 of a control element such as core wire 36 which axially moveably extends throughout the length of tubular body 26 . The proximal end 38 of the core wire 36 in the illustrated embodiment extends proximally from the core wire port 32 .
- a control element such as core wire 36 which axially moveably extends throughout the length of tubular body 26 .
- the proximal end 38 of the core wire 36 in the illustrated embodiment extends proximally from the core wire port 32 .
- the needle 44 is preferably axially moveable between a first position in which the tip 50 is contained within the distal end 24 of the tubular body 26 and a distal position in which the distal tip 50 of the needle 44 is exposed beyond the distal end of the body 26 such as for piercing the fossa ovalis. Distal advancement of the proximal end 38 of core wire 36 will advance the needle 44 from the first position to the second position as will be appreciated in view of the disclosure herein. Alternatively, the needle 44 and core wire 36 may be removed entirely from the dilator 20 except when desired to pierce the septum.
- the proximal end 38 of the core wire may be exposed beyond the proximal end of core wire port 32 as in the illustrated embodiment, such that the physician can grasp the core wire 36 and advance it distally with optimum tactile feedback.
- the proximal end 38 of core wire 36 may be connected to any of a wide variety of controls such as a slider switch, rotatable knob or other control attached to or adjacent the manifold 28 . Manipulation of the control can controllably reciprocally move the needle 44 between the first and second position.
- the needle 44 removably extends throughout the entire length of the dilator 20 .
- needle 44 may have an axial length of from about 100 cm to about 120 cm or longer, and, in one embodiment, about 110 cm.
- radiopaque dye can be injected through the central lumen 39 , and through the hollow needle 44 (if present) for assessing the position of the distal end 24 of the dilator 20 .
- blood may be withdrawn and analyzed for O2 content by well known methods. Left atrial blood will have an O2 saturation of greater than 90%, whereas right atrial blood has an O2 saturation of less than 80%.
- a separate injection lumen (not illustrated) can be readily provided if desired for a particular application.
- the needle 44 may be removable from the dilator 20 . In this construction, the dilator 20 retains its greatest flexibility such as for advancement to the intraatrial access site.
- the piercing structure 42 such as needle 44 can be loaded into the proximal end 22 of the dilator 20 and advance distally throughout the length of the dilator 20 and out a distal aperture 45 .
- the piercing structure 42 may be proximally retracted and removed from the dilator, thereby leaving the central lumen fully available for subsequent therapeutic or diagnostic devices or materials.
- the needle 44 may be provided with a corkscrew thread or other helical structure 84 , such as those having substantially circular or triangular cross-sections, thereby permitting the needle 44 to penetrate the fossa ovalis 72 by rotating while moving transversely through the opening.
- a corkscrew thread or other helical structure 84 such as those having substantially circular or triangular cross-sections, thereby permitting the needle 44 to penetrate the fossa ovalis 72 by rotating while moving transversely through the opening.
- the needle may be configured to create an opening when advanced in the distal direction, and to enlarge the opening when advanced back through the fossa ovalis in the proximal direction. This may be accomplished by providing additional cutting means, such as edges, on the needle 44 .
- the needle has a primary cutting edge 92 that is rotatably attached to the distal end of the needle 96 . The primary cutting edge 92 punctures the fossa ovalis 72 when the needle 44 is advanced in the distal direction.
- the distal end of the needle 44 is advanced into the left atrium and the primary cutting edge 92 is rotated in the left atrium to expose one or more additional cutting surface 94 , such as by means of an axially moveable pull-wire as disclosed elsewhere herein, or by other appropriate remote control or biasing means as are well known to those ordinary skill in the art.
- Retracting the needle back through the fossa ovalis 72 in the proximal direction with the additional cutting surface 94 in the exposed configuration, as illustrated in FIG. 22 b results in a larger opening in the fossa ovalis 72 .
- the needle 44 has two or more primary cutting edges 92 that are attached to the needle 44 in a scissors-like configuration.
- the primary cutting edges 92 puncture the fossa ovalis when the needle 44 is advanced in the distal direction.
- the primary cutting edges 92 can be opened in the left atrium to expose one or more additional cutting surfaces 94 , such as by means of an axially moveable pull-wire as disclosed elsewhere herein, or by other appropriate remote control or biasing means as are well known to those ordinary skill in the art.
- Retracting the needle back through the fossa ovalis 72 in the proximal direction with the additional cutting surfaces 94 in the exposed configuration results in a larger opening in the fossa ovalis 72 .
- the needle 44 has two or more wings 90 that are contained within the needle 44 when the needle 44 is advanced in the distal direction.
- the wings 90 are optionally biased to expand when the needle 44 has crossed the fossa ovalis.
- the wings 90 are expanded from the proximal end of the needle 44 such as by means of an axially moveable pull-wire as disclosed elsewhere herein, or by other appropriate remote control or biasing means as are well known to those ordinary skill in the art.
- expanding the wings 90 exposes secondary cutting surfaces 94 . Retracting the needle back through the fossa ovalis 72 in the proximal direction with the additional cutting surfaces 94 in the exposed configuration results in a larger opening in the fossa ovalis 72 .
- the wings 90 may be configured with secondary cutting surfaces 94 inclined at an angle extending toward the proximal end of the needle.
- the wings 90 may be configured with rounded secondary cutting surfaces 94 .
- the wings 90 may also be inclined at an angle extending toward the distal end of the needle or at an angle perpendicular to the axis of the needle.
- the wings 90 may be withdrawn back into the needle 44 by advancing the needle 44 distally into the dilator 20 .
- secondary cutting surfaces can be used with, or without, a dilator 20 .
- the optimal type of dilator, if any, to use with a needle having one or more secondary cutting surfaces will depend on the particular application as well as the design of the primary and secondary cutting surfaces, and can be determined though routine experimentation.
- the cutting surfaces or other dilatation surfaces are advanceable from a first, reduced crossing profile for advancement in a first direction (e.g., distally through the fossa ovalis), and a second, enlarged crossing profile for movement in a second direction (e.g., proximal retraction back through the fossa ovalis).
- a first direction e.g., distally through the fossa ovalis
- a second, enlarged crossing profile for movement in a second direction e.g., proximal retraction back through the fossa ovalis.
- Any of a variety of structures can be utilized, in which the cutting surface or tissue engagement surface is moveable from a first orientation in which it extend generally parallel to the longitudinal axis of the needle or other catheter component for penetration through a tissue surface, and a second, inclined orientation with respect to the longitudinal axis to present a larger cross sectional area.
- Such structures may be biased in the direction of the second, enlarged crossing profile and restrained by a movable sheath, pull wire or other retention structure.
- the tissue engagement surface may be neutrally biased, and moved between the reduced crossing profile and enlarged crossing profile orientations by axial movement of a pull wire.
- such structures may be advanced into the enlarged crossing profile by inflation of an underlying balloon in communication with the proximal end of the catheter by an axially extending inflation lumen.
- the distal end 24 of dilator 20 is provided with a tapered frustro conical surface 27 .
- This allows the tubular body 26 to function as a dilator, thereby permitting the tapered surface 27 to enlarge the opening formed by needle 44 while minimizing “tenting” of the fossa ovalis during the transseptal access procedure.
- the distal end 24 of dilator 20 may be provided with a corkscrew or other helical structure 84 , such as those having threads with semi-circular or triangular cross-sections, thereby permitting the dilator to enlarge the opening formed by needle 44 by rotating while moving transversely through the opening.
- the distal end 24 of dilator 20 may be provided with one or more nozzles 86 capable of generating a high-pressure stream 88 of fluid, such as saline solution, thereby enlarging the opening formed by needle 44 .
- the dilator 20 may be transversely advanced while the dilator 20 is spinning or rotating with respect to the fossa ovalis.
- the right atrium may be initially accessed with a transseptal access system through either the inferior or superior vena cava, which initially requires cannulation with an introducer sheath such as through the well known “Seldinger” technique.
- the transseptal access system of the present invention includes a transseptal sheath, a piercing dilator catheter 20 as discussed above, and an appropriately sized guidewire.
- the sheath 74 comprises an elongate, flexible tubular body having preset bends as described below.
- the sheath 74 comprises a first substantially linear section 100 , a first curved section 110 and a second curved section 130 .
- the term substantially linear also encompasses structures that are actually linear.
- the first curved section 110 is distal to the first substantially linear section 100
- the second curved section 130 is distal to the first curved section 110 .
- the first curved section 110 transitions directly into the second curved section 130 so there is no second substantially linear section 120 , and in other embodiments there is no third substantially linear section 140 distal to the second curved section.
- the sheath is designed to facilitate access to the left atrium. In other embodiments, the sheath is designed to facilitate access to other physiological structures, such as the LAA, the orifice of the LAA, the distal aspect of the LAA, or pulmonary vein such as the left superior pulmonary vein.
- the first curved section is shaped to abut the interior wall of the right atrium substantially opposite the fossa ovalis while directing the distal tip toward the fossa ovalis.
- the second curved section is shaped to facilitate location and access of the desired region of the LAA after penetration of the fossa ovalis.
- One of ordinary skill in the art will recognize that the precise shape of these curves will depend on the patient's physiology and can be determined through routine experimentation.
- the first and second curved sections may be provided in accordance with any of a variety of techniques.
- the first and second curved sections may be introduced prior to insertion of the sheath into the body by bending the sheath, such as around a forming mandrel under heat or in excess of the elastic limit of the sheath.
- an injection molded sheath body may be provided with a predetermined bend, or by heat setting such as with removable flexible mandrels extending through any interior lumen to maintain patency of the lumen around the bend.
- the first and second curved sections may be formed during or after placement of the sheath in the patient.
- This may be accomplished by providing the sheath with any of a variety of steering mechanisms, which allow a distal portion of the sheath to be inclined away from the axis of the normal bias of the catheter.
- one or more axially moveable pull wires may extend through the length of the sheath. Proximal traction on a pull wire that is secured at a distal location of the catheter will cause a lateral defection of the catheter.
- Other techniques will be known to those of skill in the art.
- the point where the first substantially linear section 100 begins to transition into the first curved section 110 defines a first proximal edge point A on the outside edge of the exterior of the sheath.
- a tangent 200 to the outer edge of the first curved section 110 at the first proximal edge point A is substantially parallel to the first substantially linear section 100 .
- the point where the first curved section 110 begins to transition into the second substantially linear section 120 defines a first distal edge point B on the outside edge of the exterior of the sheath.
- a tangent 210 to the outer edge of the first curved section 110 at the first distal edge point B is substantially parallel to the second substantially linear section 120 .
- the first distal edge point B is defined as the first inflection point distal to the first curved section 110 on the outside edge of the exterior of the sheath.
- a tangent 210 to the outer edge of the first curved section 110 at the first distal edge point B is substantially parallel to the outside edge of the exterior of the sheath at point B.
- the point where the second substantially linear section 120 begins to transition into the second curved section 130 defines a second proximal edge point C on the outside edge of the exterior of the sheath.
- a tangent 220 to the outer edge of the second curved section 130 at the second proximal edge point C is substantially parallel to the second substantially linear section 120 .
- the second proximal edge point C is defined as the first inflection point proximal to the second curved section 130 .
- a tangent 220 to the outer edge of the second curved section 130 at the second proximal edge point C is substantially parallel to the outside edge of the exterior of the sheath at point C.
- the point where the second curved section 130 begins to transition into the third substantially linear section 140 defines a second distal edge point D on the outside edge of the exterior of the sheath.
- a tangent 230 to the outer edge of the second curved section 130 at the second distal edge point D is substantially parallel to the third substantially linear section 140 .
- the second distal edge point D is defined as the distal end point of the outside edge of the exterior of the sheath.
- the second distal edge point D is defined as the first inflection point distal to the second curved section 130 .
- a tangent 220 to the outer edge of the second curved section 130 at the first distal edge point B is substantially parallel to the outside edge of the exterior of the sheath at point B.
- the tangent 200 and the tangent 210 intersect to form an angle.alpha.
- the angle.alpha. is preferably about 90 degrees, generally between about 75 degrees and about 105 degrees, and in other embodiments may be in the range of about 80 degrees to about 100 degrees.
- the tangent 220 and the tangent 230 intersect to form an angle.beta.
- the angle.beta. is preferably about 90 degrees, generally between about 75 degrees and about 105 degrees, and in other embodiments may be in the range of about 80 degrees to about 100 degrees.
- the tangent 200 and the tangent 210 also define a plane, 240 .
- the tangent 220 and the tangent 230 also define a plane, 250 .
- the plane 240 and the plane 250 define an angle.gamma.
- the angle.gamma. is preferably about 90 degrees, generally between about 75 degrees and about 105 degrees and in other embodiments may be in the range of about 80 degrees to about 100 degrees.
- the first curved section 110 has an arc length along the outside edge of the exterior of the sheath between point A and point B in the range of about 7.5 cm to about 9.5 cm.
- the second curved section 120 has an arc length along the outside edge of the exterior of the sheath between point C and point D in the range of about 5 cm to about 7.5 cm.
- the sheath also defines a Cartesian coordinate system.
- the origin of this coordinate system is defined as point A.
- the X-axis is defined as parallel to tangent 200 .
- the Y-axis is defined as the normal to tangent 200 in plane 240 .
- the Z-axis is defined as the normal to plane 240 at point A.
- the distance along the Y-axis between point A and point D is about 9 cm. In other embodiments, one of ordinary skill in the art will appreciate that the distance may vary depending upon the patient's physiology, for example within the range of about 6 cm to about 15 cm. In one embodiment, the distance along the Z-axis between point C and point D is about 3.5 cm. In other embodiments, one of ordinary skill in the art will appreciate that the distance may vary depending upon the patient's physiology, for example within the range of about 1 cm to about 6 cm.
- the first curved section 110 has a radius of curvature of about 5 cm. In other embodiments, one of ordinary skill in the art will appreciate that the radius of curvature may vary depending upon the patient's physiology, for example within the range of about 3 cm to about 10 cm. In one embodiment, the second curved section 130 has a radius of curvature of about 3 cm. In other embodiments, one of ordinary skill in the art will appreciate that the radius of curvature may vary depending upon the patient's physiology, for example within the range of about 1 cm to about 6 cm.
- the sheath is sufficiently tourqueable that the location of the distal tip of the sheath can be controlled from the proximal end of the sheath.
- additional torquability is supplied by re-enforcing the shaft with stainless steel or high strength thin polymeric braid. It is desirable to maximize the lubricity of the inner surface of the sheath to facilitate insertion and removal of various diagnostic and treatment devices within the sheath.
- the inner surface of the sheath is coated with lubricity enhancing material, such as PTFE.
- Manageability and atraumaticity are facilitated by varying the stiffness of the sheath along its length. It is desirable for the proximal section of the sheath to be relatively more stiff for torquability and kink resistance, and for the distal section of the sheath to be relatively less stiff. Generally, it is advantageous to soften the material comprising the sheath, and/or to make the wall of the sheath thinner toward the distal end.
- the proximal section of the sheath comprises 70D Pebax and has a wall thickness of about 0.015 inches
- the intermediate section of the sheath comprises 40D Pebax and has a wall thickness of about 0.015 inches
- the distal section of the sheath comprises 40D Pebax and has a wall thickness of about 0.011 inches.
- the proximal section of the sheath extends for about 55 cm
- the intermediate section of the sheath extends for about 13 cm
- the distal section of the sheath extends for about 2 cm.
- the proximal section of the sheath may extend from about 40 cm to about 65 cm
- the intermediate section of the sheath may extend from about 5 cm to about 15 cm
- the distal section of the sheath may extend from about 2 mm to about 50 mm.
- the shaft may be made of a greater or lesser number of sections having varying compositions and durometer hardnesses, that there may be gradual or abrupt transition between the sections, that the various sections may comprise a variety of other materials, and that the thickness of the sheath wall may also be adjusted.
- the desired combination of these parameters will depend on which parameters are selected and particularly useful combinations of these properties will be apparent to one of ordinary skill in the art through routine testing.
- the atraumacity of the transition between the needle, dilator, transition catheter or the like may be enhanced by tapering the outer diameter of the distal tip of the sheath and/or tapering the thickness of the wall of the distal tip of the sheath.
- Visualization of the sheath can be enhanced by marking the distal tip of the sheath a radiopaque marker.
- the radiopaque marker may be applied as a band, or in other shapes and at varying distances from the distal tip.
- the detrimental effect of drawing air into the catheter can be minimized by providing grooves, vents or holes adjacent the distal end of the sheath. This prevents the creation of a vacuum during the withdrawal of devices from the sheath by allowing blood into the sheath even if the distal opening of the sheath is in sealing contact with tissue.
- the vents 80 are slits in the distal end of the sheath.
- the vents 80 are holes which extend transversely through the wall near the distal end of the sheath.
- the vent holes 80 may also be located within the radiopaque marker band to reduce or prevent collapsing or clogging of the vent holes.
- the vents 80 have a diameter or cross sectional area equivalent to a round vent diameter within the range of from about 0.020 inches to about 0.100 inches. Anywhere from about one to about ten or more vents may be provided. In one embodiment, approximately 4 vents, each having a diameter of about 0.040 inches are provided.
- the vents may be positioned in a single plane transverse to the longitudinal axis of the catheter as illustrated. The vents reside in a plane which is generally no more than about 5 mm from the distal end. Preferably, the vents are positioned within about 3 mm of the distal end of the catheter. Alternatively, the vents may be staggered in two or more transverse planes, depending upon the desired performance characteristics.
- the preferred access point is along the right femoral vein, although access from the left femoral vein is also possible. Access may also be achieved through a puncture in any of a variety of other veins of suitable internal diameter and the present invention is not limited in this regard.
- a conventional spring tipped guide wire is thereafter advanced through the needle into the vein and the needle is subsequently removed.
- the dilator 20 of the present invention is positioned within a sheath of the type described herein, or other well-known sheaths, such as a 14 French introducer sheath. Subsequently, the sheath and inner dilator 20 , in combination with the guide wire, are advanced through the femoral vein to the right atrium.
- FIG. 4 there is illustrated a schematic cross-section of a portion of the heart 60 .
- the right atrium 62 is communication with the inferior vena cava 64 and the superior vena cava 66 .
- the right atrium 62 is separated from the left atrium 68 by the intraatrial septum 70 .
- the fossa ovalis 72 is located on the intraatrial septum 70 .
- the sheath 74 having the dilator 20 therein and a guidewire 76 have been positioned within the right atrium 62 .
- the guidewire 76 is thereafter distally advanced to access the superior vena cava 66 . See FIG. 5 .
- the dilator 20 and sheath 74 are thereafter advanced into the superior vena cava as illustrated schematically in FIG. 6 .
- the guidewire 76 is proximally retracted.
- a transseptal needle 44 is advanced through the central lumen 39 of the dilator 20 and sheath 74 .
- the transseptal needle 44 is advanced (possibly with a stylet in place) to a point that the stylet tip is just inside the distal tip of the sheath 74 and dilator 20 , a position previously noted by the operator, and the stylet is withdrawn from the transseptal needle.
- the remaining combination of the sheath 74 with the dilator 20 having the transseptal needle therein is then drawn proximally from the superior vena cava while the first curved section 110 of the sheath, alone or in combination with the preset curve 25 at the distal region of dilator 20 , causes the tip of the sheath-dilator-transseptal needle combination to “drag” along the wall of the right atrium and the septum 70 .
- some differences in the access method will occur at this point.
- the light source and detector 37 will likely need to be calibrated once the dilator 20 has been placed inside the right atrium 62 but before the tip has been placed against the septum 70 .
- the tip of the dilator 20 is then positioned against the septum 70 by distal advancement through the sheath 74 .
- the tip is then dragged along the septum by proximal traction on the dilator 20 until the tip pops onto the fossa 72 .
- the characteristic color at the fossa is detected by the detector 37 .
- a responsive audio or visual signal is generated, confirming that the catheter 20 is now properly positioned at the fossa ovalis 72 .
- the physician is normally assisted during placement, as in the entire procedure, by fluoroscopy or other visualization techniques.
- the distal tip of sheath 74 and the distal tip of dilator 20 may be provided with a radiopaque marker.
- some physicians find it desirable to infuse a radiopaque dye through the transseptal needle at various stages of the procedure to assist in visualization, particularly following the transseptal puncture.
- the transseptal needle 44 is abruptly advanced to accomplish a quick puncture. See FIG. 8 .
- the needle is advanced by applying a force to the proximal end of the needle.
- the needle often comprises a stiff proximal section and a flexible distal section.
- the distal section preferably comprises ribbon coil.
- the needle 44 is loaded into needle cavity 89 against a distal advancement biasing means 85 , such as a spring or coil. The needle 44 is held against the biasing means 85 by a release lock 87 .
- the release lock 87 may comprise any commonly used retaining means, such as corresponding inward and outward projections, grooves or flanges on the needle cavity 89 and the needle 44 .
- the distal end of the sheath 74 is placed in the desired location against the fossa ovalis 72 .
- the release lock 87 is opened and the biasing means rapidly advances the needle 44 through the fossa ovalis 72 .
- one medical technique is to confirm the presence of the tip 50 of the transseptal needle 44 within the left atrium 68 .
- Confirmation of such location of the tip 50 of the transseptal needle 44 may be accomplished by monitoring the pressure sensed through the transseptal needle lumen to ensure that the measured pressure is within the expected range and has a waveform configuration typical of left atrial pressure.
- proper position within the left atrium 68 may be confirmed by analysis of oxygen saturation level of the blood drawn through the transseptal needle 44 ; i.e., aspirating fully oxygenated blood.
- visualization through fluoroscopy alone, or in combination with the use of dye may also serve to confirm the presence of the tip 50 of the transseptal needle 44 in the left atrium 68 .
- the tip 27 of the dilator 20 is advanced through the septum 70 and into the left atrium 68 .
- care is taken to ensure that, at the same time of advancing the dilator and sheath tip into the left atrium, the tip of the transseptal needle is not advanced a sufficient distance that the needle 44 can damage the opposing wall of the left atrium 68 .
- the transseptal needle 44 is withdrawn.
- the sheath 74 is then advanced into the left atrium 68 , either by advancing the sheath 74 alone over the dilator 20 or by advancing the sheath 74 and dilator 20 in combination. See FIG. 10 .
- the dilator 20 is then withdrawn from sheath 74 when the latter has been advanced into the left atrium, thus leaving the main lumen of sheath 74 as a clear pathway to advancing further diagnostic or therapeutic instruments into the left atrium.
- the needle 44 is optionally coated with a lubricous material, often a material such as PTFE, hydrophilic material or parylene, preferably PTFE.
- the dilator 20 is also optionally coated with a lubricous material, often a material such as PTFE, hydrophilic material or parylene, preferably PTFE.
- the sheath 74 contains an inflatable balloon 77 at the distal end and means for inflating the balloon 75 , such as an inflation lumen.
- the balloon 77 is in a deflated position as the needle 44 crosses the fossa ovalis.
- the balloon 77 is disposed around the needle 44 , and the balloon 77 is inflated as it crosses the fossa ovalis, thereby enlarging the puncture made by the needle 44 .
- This embodiment may be used with or without an additional dilator 20 as described herein.
- the balloon 77 may be deflated and withdrawn after the sheath 74 has accessed the left atrium.
- the balloon may be left inflated, or further inflated after the sheath 74 accesses the left atrium.
- the balloon 77 may be inflated after the balloon crosses the fossa ovalis.
- the inflated balloon 77 creates an atraumatic distal tip that can be navigated to access a location of interest, such as the LAA.
- the balloon prevents the sheath from unintentionally passing back through the fossa ovalis during subsequent procedures.
- At least a portion of the needle 44 , the dilator 20 and at least a distal portion of the sheath 74 are encompassed by a thin-walled jacket 82 that is made of lubricous material, preferably PTFE.
- a thin-walled jacket 82 that is made of lubricous material, preferably PTFE.
- the distal end of the jacket 82 advances across the fossa ovalis 72 with the needle 44 .
- the dilator 20 and sheath 74 then cross the fossa ovalis 72 within the jacket 82 .
- the jacket is radially enlargeable and may have a thickness in the range of about 0.05 mm to about 0.75 mm depending upon the construction material.
- the optimum material or combination of materials for coating the needle 44 , coating the dilator 20 , or forming the jacket 82 can be determined for any particular application through routine experimentation by one or ordinary skill in the art based on the disclosures herein.
- the sheath 74 is itself tapered at its distal end to encompass at least a portion of the dilator. In this embodiment the sheath 74 is preferably tapered to encompass the dilator and at least a portion of the needle 44 . In another embodiment, illustrated in FIG. 19 , the sheath 74 includes means, such as a vacuum lumen, for applying a vacuum 83 at the distal end.
- the vacuum lumen may be concentrically disposed within the needle 44 and the dilator 20 , concentrically disposed within the dilator 20 , but side by side with the needle 44 , or side by side with the dilator 20 .
- the vacuum is applied to the fossa ovalis before the needle 44 punctures the fossa ovalis.
- the vacuum is applied to the fossa ovalis after the needle punctures the fossa ovalis and before or as the dilator 20 crosses the fossa ovalis.
- the vacuum maintains the position of the fossa ovalis and reduces “tenting” during the transseptal access procedure.
- the vacuum may draw the fossa ovalis into the sheath 74 .
- the needle 44 is oscillated at ultrasonic frequencies to further reduce friction between the needle 44 and the fossa ovalis 72 .
Abstract
Disclosed is an apparatus for facilitating access to the left atrium, and specifically the left atrial appendage. The apparatus may comprise a sheath with first and second curved sections that facilitate location of the fossa ovalis and left atrial appendage. The apparatus may further comprise tissue piercing and dilating structures. Methods are also disclosed.
Description
- This is a continuation of U.S. application Ser. No. 11/228,988, filed Sep. 16, 2005, which is a continuation of U.S. application Ser. No. 10/100,270, filed Mar. 15, 2002, now U.S. Pat. No. 7,056,294, which is a continuation-in-part of U.S. patent application Ser. No. 09/549,218, filed Apr. 13, 2000, now U.S. Pat. No. 6,650,923, the disclosures of which are incorporated by reference in their entireties.
- The present invention relates to transseptal access systems for accessing the left atrium from the right atrium such as by crossing the fossa ovalis.
- The typical human heart includes a right ventricle, a right atrium, left ventricle and left atrium. The right atrium is in fluid communication with the superior vena cava and the inferior vena cava. The tricuspid valve separates the right atrium from the right ventricle. On the inner wall of the right atrium where it is separated from the left atrium is a thin walled, recessed portion, the fossa ovalis. In the heart of a fetus, the fossa ovalis is open (patent foramen), permitting fetal blood to flow between the right and left atria, bypassing the fetal lungs in favor of the placental blood flow. In most individuals, this opening closes after birth. In as many as about 20 percent of adults an opening (the patent foramen) still remains in place of the fossa ovalis between the right and left atria.
- A wide variety of diagnostic and therapeutic procedures have been developed in which a catheter is transluminally advanced into various chambers and across valves of the heart. The most difficult chamber of the heart to access with a catheter is the left atrium. Access to the left atrium through the pulmonary artery is not possible. Approaches from the left ventricle are difficult, may cause arrhythmias and may present difficulty in obtaining stable catheter positioning. Accordingly, the presently preferred method of accessing the left atrium is through a transseptal approach, achieved by catheterization of the right atrium with subsequent penetration of the interatrial septum. The reduced wall thickness and location of the fossa ovalis makes it a useful access point for a transseptal access puncture.
- A variety of risks are attendant to transseptal catheterization, in addition to the risks associated with normal heart catheterization. The primary additional risk is that associated with inaccurate identification and localization of the atrial septum and the fossa ovalis in particular. Improper placement of the catheter tip prior to the transseptal puncture presents the risk of puncture of tissue other than the interatrial septum, such as the aorta and the posterior wall of the right or left atrium. For this reason, catheterization is accompanied by fluoroscopy or other visualizing techniques to assist in properly locating the catheter tip in relation to the septum.
- The objectives of left atrial access can be either diagnostic or therapeutic. One diagnostic use is pressure measurement in the left atrium. In the setting of an obstructed mitral valve (mitral stenosis), left atrial access allows a determination of the pressure difference between the left atrium and left ventricle. Left atrial access also allows entry into the left ventricle through the mitral valve. This is desirable when an artificial aortic valve is in place. The advent of aortic valve replacement with mechanical artificial valves, and the increase in the aged population and growing longevity of that population subsequent to aortic valve replacement, brings a greater need to evaluate the late stage functionality of such artificial valves.
- Diagnostic measurement of the left ventricular pressures are, therefore, desirable to allow evaluation of mechanical artificial aortic valves post-replacement. It may be unsafe to cross these mechanical artificial valves retrograde from the aorta; therefore, access to the left ventricle by the antegrade route using a transseptal puncture is the preferred approach. Once a catheter has been placed in the left atrium using the transseptal approach, access to the left ventricle can be gained by advancing catheters across the mitral valve.
- Many diagnostic indications exist for left atrial pressure measurements in addition to evaluating the functionality of artificial mitral valves. Other diagnostic indications for accessing the left ventricle via the antegrade transseptal approach include aortic stenosis, when a cardiologist is unable to pass a catheter retrograde into the left ventricle, and some disease states where the antegrade approach is considered preferable, such as subaortic obstruction.
- Presently, the therapeutic objectives of left atrial access are primarily two-fold. The first is mitral valvuloplasty which represents an alternative to surgical procedures to relieve obstruction of the mitral valve. The second therapeutic objective is for electrophysiological intervention in the left atrium. Catheter ablation involves the placement of energy (typically RF) through a catheter, into various locations of the heart to eradicate inappropriate electrical pathways affecting the heart function. When these locations are in the left atrium, the catheter through which the radio frequency generator is placed typically is itself placed with transseptal catheterization. More recently, therapeutic treatment of the left atrial appendage (LAA) to reduce the risk of embolic stroke has also been proposed.
- Despite clinical acceptance of a wide variety of procedures which require access to the left atrium, significant room for improvement remains in the actual access technique. For example, the step of locating an appropriate site on the septum such as the fossa ovalis is highly technique dependant and can be inaccurate. This increases procedure time, and creates a risk that the needle will pierce the heart wall in an unnecessary and potentially undesirable location. Thus, there remains a need for a device and method for quickly and accurately locating and piercing the fossa ovalis to permit rapid and accurate transseptal access.
- In accordance with one aspect of the present invention, there is provided a transseptal access sheath comprising; a first curved section, and a second curved section; the first curved section having an outer edge that defines a first proximal edge point, and a first distal edge point, wherein the intersection between a tangent drawn to the first curved section at the first proximal edge point and a tangent drawn to the first curved section at the first distal edge point, define a first angle and a first plane; the second curved section having an outer edge that defines a second proximal edge point, and a second distal edge point; wherein the intersection between a tangent drawn to the second curved section at the second proximal edge point and a tangent drawn to the second curved section at the second distal edge point, define a second angle and a second plane; wherein the first angle is within the range of about 60 to about 120 degrees; wherein the second angle is within the range of about 0 and about 180 degrees, more preferably about 60 and about 120 degrees; and wherein the angle between the first and second plane is within the range of about 60 and about 120 degrees.
- In accordance with another aspect of the present invention, there is provided a transseptal access sheath comprising; a first curved section, and a second curved section; wherein the first curved section is shaped to abut the interior wall of the right atrium substantially opposite the fossa ovalis while directing the distal tip toward the fossa ovalis; and, wherein the second curved section is shaped to facilitate location and access of a desired region of the LAA.
- In accordance with another aspect of the present invention, there is provided a transseptal access system comprising a sheath, a dilator and a needle; wherein the sheath comprises; a first curved section, and a second curved section; the first curved section having an outer edge that defines a first proximal edge point, and a first distal edge point, wherein the intersection between a tangent drawn to the first curved section at the first proximal edge point and a tangent drawn to the first curved section at the first distal edge point, define a first angle and a first plane; the second curved section having an outer edge that defines a second proximal edge point, and a second distal edge point wherein the intersection between a tangent drawn to the second curved section at the second proximal edge point and a tangent drawn to the second curved section at the second distal edge point, define a second angle and a second plane; wherein the first angle is within the range of about 90 degrees; wherein the second angle is within the range of about 90 degrees; and wherein the angle between the first and second plane is within the range of about 90 degrees.
-
FIG. 1 is a side elevational schematic view of a transseptal access system in accordance with the present invention. -
FIG. 2 is a cross-sectional view taken along the line 2-2 inFIG. 1 . -
FIG. 3 is an enlarged perspective view of the distal end of the transseptal access system ofFIG. 1 . -
FIG. 4 is a schematic cross-sectional view of a portion of the heart, showing a transseptal access catheter of the present invention within the right atrium. -
FIG. 5 is a cross-sectional view as inFIG. 4 , with the guidewire positioned in the superior vena cava. -
FIG. 6 is a cross-sectional view as inFIG. 4 , with the transseptal access catheter positioned against the wall of the superior vena cava. -
FIG. 7 is a cross-sectional view as inFIG. 4 , with the access catheter positioned against the fossa ovalis. -
FIG. 8 is a cross-sectional view as inFIG. 4 , showing tissue distention or “tenting” as the needle punctures the fossa ovalis. -
FIG. 9 is a cross-sectional view as inFIG. 8 , showing tissue distention as the dilator is advanced through the fossa ovalis. -
FIG. 10 is a cross-sectional view as inFIG. 9 , illustrating the sheath, which has been advanced over the dilator and through the septum. -
FIG. 11 is a cross-sectional view as inFIG. 10 , with the dilator removed, leaving the sheath in place across the fossa ovalis. -
FIGS. 12 and 13 are perspective schematic views of a transseptal access sheath in accordance with the present invention. -
FIGS. 14A-C are perspective views of vents in the transseptal access sheath. -
FIGS. 15A-C are side views of a dilator in accordance with one embodiment of the present invention. -
FIGS. 16A-C are side views of various dilators in accordance with further embodiments of the present invention. -
FIGS. 17A-C are side views of the jacket in accordance with one embodiment of the present invention. -
FIG. 18 is a side view of the transseptal access sheath in accordance with one embodiment of the present invention. -
FIG. 19 is a side view of the transseptal access sheath in accordance with one embodiment of the present invention. % -
FIGS. 20A and 20B are side views of the needle in accordance with one embodiment of the present invention. -
FIG. 21 is a side view of the needle in accordance with one embodiment of the present invention. -
FIGS. 22A-22H are side views of various needles in accordance with further embodiments of the present invention. - Referring to
FIG. 1 , there is disclosed adilator 20 in accordance with the present invention.Dilator 20 has aproximal end 22, adistal end 24 and an elongate flexibletubular body 26. The overall length of thedilator 20 depends upon the percutaneous access point and the desired application. For example, lengths in the area of from about 80 cm to about 100 cm are typical for use in percutaneous transluminal access at the femoral vein for locating and puncturing a site on the atrial septum in the heart. -
Tubular body 26 may be manufactured in accordance with any of a variety of known techniques, for manufacturing catheters adapted to reach the coronary arteries or chambers of the heart. For example,tubular body 26 may be manufactured as an extrusion of appropriate biocompatible polymeric materials such as high density polyethylene, polytetrafluoroethylene (PTFE), nylons, and a variety of others which are known in the art. Blended materials may also be used, such as HDPE (e.g., HDPE/LDPE ratios such as 50%:50%, 60%:40% and others) with from about 5% to about 25%, and, in one embodiment, about 20% BaSO.sub.4 for lubricity and radiopacity. Alternatively, at least a portion or all of the length oftubular body 26 may comprise a spring coil, solid walled hypodermic needle tubing (e.g., stainless steel, NiTi alloys) or braided reinforced wall as is understood in the catheter and guidewire arts. - For most applications, the
tubular body 26 is provided with an approximately circular cross sectional configuration having an outside diameter within the range of from about 0.020 inches to about 0.200 inches. In accordance with one embodiment of the invention, thetubular body 26 has an outside diameter of about 0.160 inches throughout its length. Other lengths and diameters may be readily utilized, depending upon the desired profile and performance characteristics. - The
proximal end 22 is provided with a manifold 28, having one or more access ports as in known in the art. In the illustrated embodiment,manifold 28 is provided with acore wire port 32 which may also or alternatively function as a guidewire port in an over the wire embodiment. Aninjection port 30 may also be provided, for injecting a contrast media, such as to confirm that thedistal end 24 has traversed the intraatrial septum. Additional access ports may be provided as needed, depending upon the functional capabilities of the catheter.Manifold 28 may be injection molded from any of a variety of medical grade plastics or formed in accordance with other techniques known in the art. - The
proximal end 22, either at the manifold 28 or distally of the manifold 28 is also provided with acommunication line 34 such as afiber optic bundle 35 in accordance with one aspect of the present invention. In one embodiment of the invention, fiber optic bundle or signal transmittingline 35 communicates with a signal (e.g. sound, light, ultrasonic or other vibration, etc.) generator and detector 37. In this embodiment of the invention, the detector 37 enables the catheter to distinguish among solid tissue or a thick membrane, a thin membrane such as at the fossa ovalis, and right atrial or left atrial chamber blood beyond thedistal end 24 ofdilator 20 as will be discussed. - The
flexible body 26 is provided with apreset bend 25, for assisting in biasing thedistal end 24 against the intraatrial septum as is understood in the art.Bend 25 preferably has a radius within the range of from about 0.5 cm to about 5 cm and, in one embodiment, about 2.5 cm.Bend 25 is centered on a point which is within the range of from about 1 cm to about 10 cm proximally fromdistal end 24. In one embodiment, thebend 25 is centered at approximately 6 cm proximally fromdistal end 24. Thebend 25 is defined by a proximal transition where it meets the substantially linear proximal portion of thedilator 20, and a distal transition where it meets the substantially linear distal portion of thedilator 20. The angular deflection of thebend 25 is generally within the range of from about 30.degree. to about 80.degree. and, in one embodiment, is about 50.degree. -
Bend 25 may be provided in accordance with any of a variety of techniques. For example, in an embodiment oftubular body 26 which includes a hypotube or other metal tubing, thetubular body 26 may be bent such as around a forming mandrel in excess of the elastic limit of the hypotube. Alternatively, an injection molded catheter body may be heat set in a predetermined bend, such as with removable flexible mandrels extending through any interior lumen to maintain patency of the lumen around the bend. Other techniques will be known to those of skill in the art. Alternatively, thebend 25 may be formed during or after placement of the catheter in the heart. This may be accomplished by providing the catheter with any of a variety of steering mechanisms, which allow a distal portion of the catheter to be inclined away from the axis of the normal bias of the catheter. For example, one or more axially moveable pull wires may extend throughout the length of the catheter. Proximal traction on a pull wire which is secured at the distal end of the catheter will cause a lateral defection of the catheter. - Referring to the enlarged schematic illustration of
FIG. 3 ,distal end 24 is provided with at least onesignal transmitting surface 47 and at least one signal receiving surface 49. Transmittingsurface 47 is adapted to transmit a signal from thedistal end 24 ofdilator 20 and generally in the distal direction with respect to the dilator. Receiving surface 49 is adapted for receiving a reflected return signal traveling in a generally proximal direction with respect to thedistal end 24 ofdilator 20. In one embodiment, the transmittingsurface 47 comprises the distal end of a fiber optic or fiber optic bundle, or a transparent window positioned at the distal end of a fiber optic or fiber optic bundle. Similarly, the receiving surface 49 comprises a distal end of a receiving fiber optic or a transparent window positioned distally of the receiving fiber optic. In the illustrated embodiment, two transmittingsurfaces 47 and two receiving surfaces 49 are provided each communicating with the spectrometer 37 via aunique communication line 34. - Transmission and reception of, for example, visible light, can alternatively be accomplished though a single transparent window, and embodiments in which the transmission and reception signals are propagated through the same fiber optic or through closely adjacent fiber optics are also contemplated. Propagation of transmission and reception signals through the same fiber optic can be accomplished such as by the provision of a coupler at the proximal end to split the transmission and reception signals for processing at detector 37 as will be understood in, among others, the blood oximetry detector arts. Alternatively, one or more separate transmit
surfaces 47 and receiving surfaces 49 may be provided, and anywhere within the range of from about 1 to about 12 of each transmitsurface 47 and receiving surface 49 may be provided as desired. - Signal transmitting
bundle 35 thus provides communication between the transmitsurface 47 and receiving surface 49, and a detector 37 such as a spectrometer which remains outside of the patient. The construction and use of spectrometers such as to measure RGB and other UV, visible and IR wavelengths is well understood in the pulse oximetry art, among others, and will not be disclosed in detail herein. In general, transmitter/detector 37 is able to transmit multiple wavelengths of light, which propagate beyond the transmitsurface 47 and into a target beyond thedistal end 24 of thedilator 20. Some of the transmitted light is absorbed in the target, while other transmitted light is reflected back and received at receiving surface 49. The reflected light is thereafter propagated to the light detector 37 for processing. The present inventors have determined that the light detector 37 in combination with the dilator of the present invention can identify when thedistal end 24 of thedilator 20 is positioned against the fossa ovalis of the intraatrial septum, as opposed to other portions of the septum or muscle wall, due to the unique characteristics of light observed at the fossa ovalis. - Depending upon the characteristics of the transmitted light, reflected light at the fossa ovalis will exhibit unique characteristics imparted by (1) light reflected at the surface of or within the fossa ovalis, (2) light reflected through the fossa ovalis by blood in the left atrium, or (3) a combination of the foregoing. The ability of an optical detector to locate the fossa based upon light propagated through the fossa is based upon several circumstances. The blood in the right atrium is relatively poorly oxygenated, and therefore more blue than red. The left atrium contains well oxygenated blood which tends to be relatively red. The fossa is thin enough to allow light to be transmitted across the fossa and into and from the left atrium while the fossa locator is still on the right atrial side. All other areas of the septum are generally thick enough that they will not allow significant light transmission between the right atrium and the left atrium. Thus, in an embodiment of the invention which utilizes light transmission through the fossa, the location of relatively red blood indicates transmission into the left atrium which will generally only happen at the fossa.
- Alternatively, the septum contains oxygenated blood and therefore has a certain level of red transmission. The fossa, however, is a thin translucent membrane which is almost yellow. Non-oxygenated blood within the right atrium is relatively blue, while oxygenated blood within the left atrium is red. Location of the fossa may thus alternatively be accomplished by identifying the presence of a translucent, near yellow membrane. The use of multiple wavelengths, transmission, and detectors will allow assessment of both the near yellow color of the fossa, as well as the red color identified through the fossa as will be apparent to those of skill in the art in view of the disclosure herein.
- The method of the present invention may additionally be accomplished by providing a light source within the left atrium. The left atrium light source may be provided on any of a variety of left atrium access catheters, as will be apparent to those of skill in the art. Light generated in the left atrium, will be detectable in the right atrium either exclusively at the fossa, or with a greatest intensity appearing at the fossa. Thus, the
left atrium dilator 20 need only be provided with light detector optics and electronics, to identify the fossa based upon the characteristics of light received from the right atrium light source. - The
dilator 20 is additionally provided with atissue piercing structure 42 such as aneedle 44.Needle 44 preferably comprises a tubular structure such as a stainless steel hypotube having a sharpeneddistal end 50. The sharpeneddistal end 50 ofneedle 44 is axially moveable advanceable through anaperture 45 in thedistal end 24 of thetubular body 26. - In one embodiment of the invention, the
needle 44 has an axial length of from about 1 cm to about 5 cm, an inside diameter of about 0.022 inches and an outside diameter of about 0.032 inches. Any of a variety of other dimensions forneedle 44 may also be used depending upon the desired performance and overall catheter dimensions.Needle 44 is connected to thedistal end 40 of a control element such ascore wire 36 which axially moveably extends throughout the length oftubular body 26. Theproximal end 38 of thecore wire 36 in the illustrated embodiment extends proximally from thecore wire port 32. Theneedle 44 is preferably axially moveable between a first position in which thetip 50 is contained within thedistal end 24 of thetubular body 26 and a distal position in which thedistal tip 50 of theneedle 44 is exposed beyond the distal end of thebody 26 such as for piercing the fossa ovalis. Distal advancement of theproximal end 38 ofcore wire 36 will advance theneedle 44 from the first position to the second position as will be appreciated in view of the disclosure herein. Alternatively, theneedle 44 andcore wire 36 may be removed entirely from thedilator 20 except when desired to pierce the septum. - The
proximal end 38 of the core wire may be exposed beyond the proximal end ofcore wire port 32 as in the illustrated embodiment, such that the physician can grasp thecore wire 36 and advance it distally with optimum tactile feedback. Alternatively, theproximal end 38 ofcore wire 36 may be connected to any of a wide variety of controls such as a slider switch, rotatable knob or other control attached to or adjacent themanifold 28. Manipulation of the control can controllably reciprocally move theneedle 44 between the first and second position. - In an alternate embodiment, disclosed in
FIGS. 6-10 , theneedle 44 removably extends throughout the entire length of thedilator 20. For this embodiment,needle 44 may have an axial length of from about 100 cm to about 120 cm or longer, and, in one embodiment, about 110 cm. - In the illustrated embodiment, radiopaque dye can be injected through the
central lumen 39, and through the hollow needle 44 (if present) for assessing the position of thedistal end 24 of thedilator 20. Alternatively, blood may be withdrawn and analyzed for O2 content by well known methods. Left atrial blood will have an O2 saturation of greater than 90%, whereas right atrial blood has an O2 saturation of less than 80%. A separate injection lumen (not illustrated) can be readily provided if desired for a particular application. In addition, theneedle 44 may be removable from thedilator 20. In this construction, thedilator 20 retains its greatest flexibility such as for advancement to the intraatrial access site. Once thedistal end 24 of thedilator 20 is positioned within the left atrium, the piercingstructure 42 such asneedle 44 can be loaded into theproximal end 22 of thedilator 20 and advance distally throughout the length of thedilator 20 and out adistal aperture 45. Once the piercingstructure 42 has pierced the fossa ovalis or other structure, and thedistal end 24 of thedilator 20 is advanced through the opening formed by the piercing structure, the piercingstructure 42 may be proximally retracted and removed from the dilator, thereby leaving the central lumen fully available for subsequent therapeutic or diagnostic devices or materials. - In one embodiment, illustrated in
FIG. 21 , theneedle 44 may be provided with a corkscrew thread or otherhelical structure 84, such as those having substantially circular or triangular cross-sections, thereby permitting theneedle 44 to penetrate thefossa ovalis 72 by rotating while moving transversely through the opening. One of ordinary skill in the art will appreciate that the size, shape and orientation of the helical structures can be adjusted depending on the desired combination of minimizing resistance during puncture or increasing the size of opening. - Where it is desirable to increase the size of the opening created by the
needle 44, the needle may be configured to create an opening when advanced in the distal direction, and to enlarge the opening when advanced back through the fossa ovalis in the proximal direction. This may be accomplished by providing additional cutting means, such as edges, on theneedle 44. In one embodiment, illustrated inFIG. 22 a, the needle has aprimary cutting edge 92 that is rotatably attached to the distal end of theneedle 96. Theprimary cutting edge 92 punctures thefossa ovalis 72 when theneedle 44 is advanced in the distal direction. The distal end of theneedle 44 is advanced into the left atrium and theprimary cutting edge 92 is rotated in the left atrium to expose one or more additional cuttingsurface 94, such as by means of an axially moveable pull-wire as disclosed elsewhere herein, or by other appropriate remote control or biasing means as are well known to those ordinary skill in the art. Retracting the needle back through thefossa ovalis 72 in the proximal direction with theadditional cutting surface 94 in the exposed configuration, as illustrated inFIG. 22 b, results in a larger opening in thefossa ovalis 72. - In another embodiment, illustrated in
FIG. 22 c, theneedle 44 has two or more primary cutting edges 92 that are attached to theneedle 44 in a scissors-like configuration. The primary cutting edges 92 puncture the fossa ovalis when theneedle 44 is advanced in the distal direction. The primary cutting edges 92 can be opened in the left atrium to expose one or more additional cutting surfaces 94, such as by means of an axially moveable pull-wire as disclosed elsewhere herein, or by other appropriate remote control or biasing means as are well known to those ordinary skill in the art. Retracting the needle back through thefossa ovalis 72 in the proximal direction with the additional cutting surfaces 94 in the exposed configuration, as illustrated inFIG. 22 d, results in a larger opening in thefossa ovalis 72. - In another embodiment, illustrated in
FIG. 22 e, theneedle 44 has two ormore wings 90 that are contained within theneedle 44 when theneedle 44 is advanced in the distal direction. Thewings 90 are optionally biased to expand when theneedle 44 has crossed the fossa ovalis. Alternatively, thewings 90 are expanded from the proximal end of theneedle 44 such as by means of an axially moveable pull-wire as disclosed elsewhere herein, or by other appropriate remote control or biasing means as are well known to those ordinary skill in the art. As illustrated inFIGS. 22 f and 22 g, expanding thewings 90 exposes secondary cutting surfaces 94. Retracting the needle back through thefossa ovalis 72 in the proximal direction with the additional cutting surfaces 94 in the exposed configuration results in a larger opening in thefossa ovalis 72. - As illustrated in
FIG. 22 f, thewings 90 may be configured with secondary cutting surfaces 94 inclined at an angle extending toward the proximal end of the needle. Alternatively, as illustrated inFIG. 22 g, thewings 90 may be configured with rounded secondary cutting surfaces 94. Thewings 90 may also be inclined at an angle extending toward the distal end of the needle or at an angle perpendicular to the axis of the needle. As illustrated inFIG. 22H , in those embodiments where the secondary cutting surfaces 94 are rounded or inclined at an angle extending toward the distal end of the needle, thewings 90 may be withdrawn back into theneedle 44 by advancing theneedle 44 distally into thedilator 20. - Although certain embodiments incorporating secondary cutting surfaces have been illustrated in conjunction with a
dilator 20 as disclosed herein, one of ordinary skill in the art will appreciate that secondary cutting surfaces can be used with, or without, adilator 20. The optimal type of dilator, if any, to use with a needle having one or more secondary cutting surfaces will depend on the particular application as well as the design of the primary and secondary cutting surfaces, and can be determined though routine experimentation. - In general, the cutting surfaces or other dilatation surfaces are advanceable from a first, reduced crossing profile for advancement in a first direction (e.g., distally through the fossa ovalis), and a second, enlarged crossing profile for movement in a second direction (e.g., proximal retraction back through the fossa ovalis). Any of a variety of structures can be utilized, in which the cutting surface or tissue engagement surface is moveable from a first orientation in which it extend generally parallel to the longitudinal axis of the needle or other catheter component for penetration through a tissue surface, and a second, inclined orientation with respect to the longitudinal axis to present a larger cross sectional area. Such structures may be biased in the direction of the second, enlarged crossing profile and restrained by a movable sheath, pull wire or other retention structure. Alternatively, the tissue engagement surface may be neutrally biased, and moved between the reduced crossing profile and enlarged crossing profile orientations by axial movement of a pull wire. As a further alternative, such structures may be advanced into the enlarged crossing profile by inflation of an underlying balloon in communication with the proximal end of the catheter by an axially extending inflation lumen.
- As illustrated in
FIG. 16A , thedistal end 24 ofdilator 20 is provided with a tapered frustroconical surface 27. This allows thetubular body 26 to function as a dilator, thereby permitting the taperedsurface 27 to enlarge the opening formed byneedle 44 while minimizing “tenting” of the fossa ovalis during the transseptal access procedure. Alternatively, as illustrated inFIG. 16 b, thedistal end 24 ofdilator 20 may be provided with a corkscrew or otherhelical structure 84, such as those having threads with semi-circular or triangular cross-sections, thereby permitting the dilator to enlarge the opening formed byneedle 44 by rotating while moving transversely through the opening. In yet another embodiment, illustrated inFIG. 16 c, thedistal end 24 ofdilator 20 may be provided with one ormore nozzles 86 capable of generating a high-pressure stream 88 of fluid, such as saline solution, thereby enlarging the opening formed byneedle 44. Optionally, in all of these embodiments, thedilator 20 may be transversely advanced while thedilator 20 is spinning or rotating with respect to the fossa ovalis. - Various embodiments of the present invention have been disclosed wherein the
needle 44 anddilator 20 have been described as separate structures. One of ordinary skill in the art will recognize that the needle and dilator need not be physically separate structures and will appreciate that the allocation of particular features to the needle or dilator is illustrative only. For any particular application, the optimal allocation of the features disclosed herein as part of a single physical structure or physically part of either the needle or dilator will be apparent to one or ordinary skill in the through routine experimentation. - In accordance with the method of the present invention, the right atrium may be initially accessed with a transseptal access system through either the inferior or superior vena cava, which initially requires cannulation with an introducer sheath such as through the well known “Seldinger” technique. The transseptal access system of the present invention includes a transseptal sheath, a piercing
dilator catheter 20 as discussed above, and an appropriately sized guidewire. - Illustrated in
FIG. 12 is an embodiment of anaccess sheath 74. In general, thesheath 74 comprises an elongate, flexible tubular body having preset bends as described below. In an unstressed configuration thesheath 74 comprises a first substantiallylinear section 100, a firstcurved section 110 and a secondcurved section 130. As used herein, the term substantially linear also encompasses structures that are actually linear. The firstcurved section 110 is distal to the first substantiallylinear section 100, and the secondcurved section 130 is distal to the firstcurved section 110. Preferably, there is a second substantiallylinear section 120 between the first and second curved sections, and a third substantiallylinear section 140 distal to the second curved section. In other embodiments the firstcurved section 110 transitions directly into the secondcurved section 130 so there is no second substantiallylinear section 120, and in other embodiments there is no third substantiallylinear section 140 distal to the second curved section. - In one embodiment, the sheath is designed to facilitate access to the left atrium. In other embodiments, the sheath is designed to facilitate access to other physiological structures, such as the LAA, the orifice of the LAA, the distal aspect of the LAA, or pulmonary vein such as the left superior pulmonary vein. One of ordinary skill in the art can determine the optimum geometric orientation of the sheath for any particular application based on the desired region of access and the particular patient's physiology through routine experimentation in view of the disclosure herein. In one embodiment that is useful for accessing regions of the LAA, the first curved section is shaped to abut the interior wall of the right atrium substantially opposite the fossa ovalis while directing the distal tip toward the fossa ovalis. This facilitates location of the fossa ovalis through tactile or other sensing means as described herein. The second curved section is shaped to facilitate location and access of the desired region of the LAA after penetration of the fossa ovalis. One of ordinary skill in the art will recognize that the precise shape of these curves will depend on the patient's physiology and can be determined through routine experimentation.
- The first and second curved sections may be provided in accordance with any of a variety of techniques. For example, the first and second curved sections may be introduced prior to insertion of the sheath into the body by bending the sheath, such as around a forming mandrel under heat or in excess of the elastic limit of the sheath. Alternatively, an injection molded sheath body may be provided with a predetermined bend, or by heat setting such as with removable flexible mandrels extending through any interior lumen to maintain patency of the lumen around the bend. Alternatively, the first and second curved sections may be formed during or after placement of the sheath in the patient. This may be accomplished by providing the sheath with any of a variety of steering mechanisms, which allow a distal portion of the sheath to be inclined away from the axis of the normal bias of the catheter. For example, one or more axially moveable pull wires may extend through the length of the sheath. Proximal traction on a pull wire that is secured at a distal location of the catheter will cause a lateral defection of the catheter. Other techniques will be known to those of skill in the art.
- The geometric orientation of certain preferred embodiments that are useful for accessing regions of the LAA are described below. As will be appreciated by one of ordinary skill in the art, depending on the patient's physiology and the location to which access is sought, the objects of the invention can be achieved by varying the geometric design of the sheath without departing from spirit of the invention. In particular the invention contemplates adding additional curved sections and/or by adding additional substantially linear sections.
- In one embodiment, illustrated in
FIG. 13 , the point where the first substantiallylinear section 100 begins to transition into the firstcurved section 110 defines a first proximal edge point A on the outside edge of the exterior of the sheath. A tangent 200 to the outer edge of the firstcurved section 110 at the first proximal edge point A is substantially parallel to the first substantiallylinear section 100. The point where the firstcurved section 110 begins to transition into the second substantiallylinear section 120 defines a first distal edge point B on the outside edge of the exterior of the sheath. A tangent 210 to the outer edge of the firstcurved section 110 at the first distal edge point B is substantially parallel to the second substantiallylinear section 120. In those embodiments where there is no second substantiallylinear section 120 or where there are additional curved or substantially linear sections, the first distal edge point B is defined as the first inflection point distal to the firstcurved section 110 on the outside edge of the exterior of the sheath. A tangent 210 to the outer edge of the firstcurved section 110 at the first distal edge point B is substantially parallel to the outside edge of the exterior of the sheath at point B. - The point where the second substantially
linear section 120 begins to transition into the secondcurved section 130 defines a second proximal edge point C on the outside edge of the exterior of the sheath. A tangent 220 to the outer edge of the secondcurved section 130 at the second proximal edge point C is substantially parallel to the second substantiallylinear section 120. In those embodiments where there is no second substantiallylinear section 120 or where there are additional curved or substantially linear sections, the second proximal edge point C is defined as the first inflection point proximal to the secondcurved section 130. A tangent 220 to the outer edge of the secondcurved section 130 at the second proximal edge point C is substantially parallel to the outside edge of the exterior of the sheath at point C. - The point where the second
curved section 130 begins to transition into the third substantiallylinear section 140 defines a second distal edge point D on the outside edge of the exterior of the sheath. A tangent 230 to the outer edge of the secondcurved section 130 at the second distal edge point D is substantially parallel to the third substantiallylinear section 140. In those embodiments where there is no third substantiallylinear section 140 the second distal edge point D is defined as the distal end point of the outside edge of the exterior of the sheath. In those embodiments where there are additional curved or substantially linear sections distal to the secondcurved section 140 the second distal edge point D is defined as the first inflection point distal to the secondcurved section 130. A tangent 220 to the outer edge of the secondcurved section 130 at the first distal edge point B is substantially parallel to the outside edge of the exterior of the sheath at point B. - The tangent 200 and the tangent 210 intersect to form an angle.alpha. The angle.alpha. is preferably about 90 degrees, generally between about 75 degrees and about 105 degrees, and in other embodiments may be in the range of about 80 degrees to about 100 degrees. The tangent 220 and the tangent 230 intersect to form an angle.beta. The angle.beta. is preferably about 90 degrees, generally between about 75 degrees and about 105 degrees, and in other embodiments may be in the range of about 80 degrees to about 100 degrees. The tangent 200 and the tangent 210 also define a plane, 240. The tangent 220 and the tangent 230 also define a plane, 250. The plane 240 and the
plane 250 define an angle.gamma. The angle.gamma. is preferably about 90 degrees, generally between about 75 degrees and about 105 degrees and in other embodiments may be in the range of about 80 degrees to about 100 degrees. - The first
curved section 110 has an arc length along the outside edge of the exterior of the sheath between point A and point B in the range of about 7.5 cm to about 9.5 cm. The secondcurved section 120 has an arc length along the outside edge of the exterior of the sheath between point C and point D in the range of about 5 cm to about 7.5 cm. - The sheath also defines a Cartesian coordinate system. The origin of this coordinate system is defined as point A. The X-axis is defined as parallel to
tangent 200. The Y-axis is defined as the normal to tangent 200 in plane 240. The Z-axis is defined as the normal to plane 240 at point A. In one embodiment, the distance along the Y-axis between point A and point D is about 9 cm. In other embodiments, one of ordinary skill in the art will appreciate that the distance may vary depending upon the patient's physiology, for example within the range of about 6 cm to about 15 cm. In one embodiment, the distance along the Z-axis between point C and point D is about 3.5 cm. In other embodiments, one of ordinary skill in the art will appreciate that the distance may vary depending upon the patient's physiology, for example within the range of about 1 cm to about 6 cm. - In one embodiment, the first
curved section 110 has a radius of curvature of about 5 cm. In other embodiments, one of ordinary skill in the art will appreciate that the radius of curvature may vary depending upon the patient's physiology, for example within the range of about 3 cm to about 10 cm. In one embodiment, the secondcurved section 130 has a radius of curvature of about 3 cm. In other embodiments, one of ordinary skill in the art will appreciate that the radius of curvature may vary depending upon the patient's physiology, for example within the range of about 1 cm to about 6 cm. - Preferably the sheath is sufficiently tourqueable that the location of the distal tip of the sheath can be controlled from the proximal end of the sheath. In one embodiment additional torquability is supplied by re-enforcing the shaft with stainless steel or high strength thin polymeric braid. It is desirable to maximize the lubricity of the inner surface of the sheath to facilitate insertion and removal of various diagnostic and treatment devices within the sheath. In one embodiment the inner surface of the sheath is coated with lubricity enhancing material, such as PTFE.
- Manageability and atraumaticity are facilitated by varying the stiffness of the sheath along its length. It is desirable for the proximal section of the sheath to be relatively more stiff for torquability and kink resistance, and for the distal section of the sheath to be relatively less stiff. Generally, it is advantageous to soften the material comprising the sheath, and/or to make the wall of the sheath thinner toward the distal end. In one embodiment, the proximal section of the sheath comprises 70D Pebax and has a wall thickness of about 0.015 inches, the intermediate section of the sheath comprises 40D Pebax and has a wall thickness of about 0.015 inches, and the distal section of the sheath comprises 40D Pebax and has a wall thickness of about 0.011 inches. In one embodiment, the proximal section of the sheath extends for about 55 cm, the intermediate section of the sheath extends for about 13 cm, and the distal section of the sheath extends for about 2 cm. In other embodiments, the proximal section of the sheath may extend from about 40 cm to about 65 cm, the intermediate section of the sheath may extend from about 5 cm to about 15 cm, and the distal section of the sheath may extend from about 2 mm to about 50 mm.
- One of ordinary skill in the art will appreciate that the shaft may be made of a greater or lesser number of sections having varying compositions and durometer hardnesses, that there may be gradual or abrupt transition between the sections, that the various sections may comprise a variety of other materials, and that the thickness of the sheath wall may also be adjusted. The desired combination of these parameters will depend on which parameters are selected and particularly useful combinations of these properties will be apparent to one of ordinary skill in the art through routine testing.
- The atraumacity of the transition between the needle, dilator, transition catheter or the like may be enhanced by tapering the outer diameter of the distal tip of the sheath and/or tapering the thickness of the wall of the distal tip of the sheath. Visualization of the sheath can be enhanced by marking the distal tip of the sheath a radiopaque marker. One of ordinary skill in the art will appreciate that the radiopaque marker may be applied as a band, or in other shapes and at varying distances from the distal tip.
- The detrimental effect of drawing air into the catheter can be minimized by providing grooves, vents or holes adjacent the distal end of the sheath. This prevents the creation of a vacuum during the withdrawal of devices from the sheath by allowing blood into the sheath even if the distal opening of the sheath is in sealing contact with tissue. In one embodiment, illustrated in
FIG. 14 a, thevents 80 are slits in the distal end of the sheath. In another embodiment, illustrated inFIG. 14 b, thevents 80 are holes which extend transversely through the wall near the distal end of the sheath. As illustrated inFIG. 14 c, the vent holes 80 may also be located within the radiopaque marker band to reduce or prevent collapsing or clogging of the vent holes. - In general, the
vents 80 have a diameter or cross sectional area equivalent to a round vent diameter within the range of from about 0.020 inches to about 0.100 inches. Anywhere from about one to about ten or more vents may be provided. In one embodiment, approximately 4 vents, each having a diameter of about 0.040 inches are provided. The vents may be positioned in a single plane transverse to the longitudinal axis of the catheter as illustrated. The vents reside in a plane which is generally no more than about 5 mm from the distal end. Preferably, the vents are positioned within about 3 mm of the distal end of the catheter. Alternatively, the vents may be staggered in two or more transverse planes, depending upon the desired performance characteristics. - In present practice, the preferred access point is along the right femoral vein, although access from the left femoral vein is also possible. Access may also be achieved through a puncture in any of a variety of other veins of suitable internal diameter and the present invention is not limited in this regard.
- A conventional spring tipped guide wire is thereafter advanced through the needle into the vein and the needle is subsequently removed. The
dilator 20 of the present invention is positioned within a sheath of the type described herein, or other well-known sheaths, such as a 14 French introducer sheath. Subsequently, the sheath andinner dilator 20, in combination with the guide wire, are advanced through the femoral vein to the right atrium. - Referring to
FIG. 4 , there is illustrated a schematic cross-section of a portion of theheart 60. Theright atrium 62 is communication with theinferior vena cava 64 and thesuperior vena cava 66. Theright atrium 62 is separated from theleft atrium 68 by theintraatrial septum 70. The fossa ovalis 72 is located on theintraatrial septum 70. As seen inFIG. 4 , thesheath 74 having thedilator 20 therein and aguidewire 76 have been positioned within theright atrium 62. - The
guidewire 76 is thereafter distally advanced to access thesuperior vena cava 66. SeeFIG. 5 . Thedilator 20 andsheath 74 are thereafter advanced into the superior vena cava as illustrated schematically inFIG. 6 . Theguidewire 76 is proximally retracted. - When the
sheath 74 anddilator 20 are in the superior vena cava and the guide wire has been removed, atransseptal needle 44 is advanced through thecentral lumen 39 of thedilator 20 andsheath 74. Thetransseptal needle 44 is advanced (possibly with a stylet in place) to a point that the stylet tip is just inside the distal tip of thesheath 74 anddilator 20, a position previously noted by the operator, and the stylet is withdrawn from the transseptal needle. - The remaining combination of the
sheath 74 with thedilator 20 having the transseptal needle therein, is then drawn proximally from the superior vena cava while the firstcurved section 110 of the sheath, alone or in combination with thepreset curve 25 at the distal region ofdilator 20, causes the tip of the sheath-dilator-transseptal needle combination to “drag” along the wall of the right atrium and theseptum 70. Depending upon the particular embodiment of the transseptal access system, some differences in the access method will occur at this point. - For example, in the reflected light embodiment disclosed in connection with
FIGS. 1-3 , the light source and detector 37 will likely need to be calibrated once thedilator 20 has been placed inside theright atrium 62 but before the tip has been placed against theseptum 70. The tip of thedilator 20 is then positioned against theseptum 70 by distal advancement through thesheath 74. The tip is then dragged along the septum by proximal traction on thedilator 20 until the tip pops onto thefossa 72. Once the tip is positioned on thefossa 72, the characteristic color at the fossa is detected by the detector 37. A responsive audio or visual signal is generated, confirming that thecatheter 20 is now properly positioned at thefossa ovalis 72. - The physician is normally assisted during placement, as in the entire procedure, by fluoroscopy or other visualization techniques. To assist in such visualization, the distal tip of
sheath 74 and the distal tip ofdilator 20 may be provided with a radiopaque marker. In addition, some physicians find it desirable to infuse a radiopaque dye through the transseptal needle at various stages of the procedure to assist in visualization, particularly following the transseptal puncture. - After the tip of the sheath-dilator-transseptal needle combination has been placed in the desired location against the
fossa ovalis 72, thetransseptal needle 44 is abruptly advanced to accomplish a quick puncture. SeeFIG. 8 . In one embodiment the needle is advanced by applying a force to the proximal end of the needle. In this embodiment the needle often comprises a stiff proximal section and a flexible distal section. The distal section preferably comprises ribbon coil. Alternatively, as illustrated inFIG. 20 a, theneedle 44 is loaded intoneedle cavity 89 against a distal advancement biasing means 85, such as a spring or coil. Theneedle 44 is held against the biasing means 85 by arelease lock 87. Therelease lock 87 may comprise any commonly used retaining means, such as corresponding inward and outward projections, grooves or flanges on theneedle cavity 89 and theneedle 44. The distal end of thesheath 74 is placed in the desired location against thefossa ovalis 72. As illustrated inFIG. 20 b, therelease lock 87 is opened and the biasing means rapidly advances theneedle 44 through thefossa ovalis 72. Immediately after the puncture, one medical technique is to confirm the presence of thetip 50 of thetransseptal needle 44 within theleft atrium 68. Confirmation of such location of thetip 50 of thetransseptal needle 44 may be accomplished by monitoring the pressure sensed through the transseptal needle lumen to ensure that the measured pressure is within the expected range and has a waveform configuration typical of left atrial pressure. Alternatively, proper position within theleft atrium 68 may be confirmed by analysis of oxygen saturation level of the blood drawn through thetransseptal needle 44; i.e., aspirating fully oxygenated blood. Finally, visualization through fluoroscopy alone, or in combination with the use of dye, may also serve to confirm the presence of thetip 50 of thetransseptal needle 44 in theleft atrium 68. - After placing the
transseptal needle tip 50 within theleft atrium 68, thetip 27 of thedilator 20 is advanced through theseptum 70 and into theleft atrium 68. Typically, care is taken to ensure that, at the same time of advancing the dilator and sheath tip into the left atrium, the tip of the transseptal needle is not advanced a sufficient distance that theneedle 44 can damage the opposing wall of theleft atrium 68. When the taperedtip 27 ofdilator 20 appears to have entered theleft atrium 68, thetransseptal needle 44 is withdrawn. Thesheath 74 is then advanced into theleft atrium 68, either by advancing thesheath 74 alone over thedilator 20 or by advancing thesheath 74 anddilator 20 in combination. SeeFIG. 10 . Thedilator 20 is then withdrawn fromsheath 74 when the latter has been advanced into the left atrium, thus leaving the main lumen ofsheath 74 as a clear pathway to advancing further diagnostic or therapeutic instruments into the left atrium. - During the initial puncture of the fossa ovalis and the subsequent advancement of the
dilator 20 andsheath 74 into the left atrium, it is desirable to minimize “tenting” of the fossa ovalis. Theneedle 44 is optionally coated with a lubricous material, often a material such as PTFE, hydrophilic material or parylene, preferably PTFE. Thedilator 20 is also optionally coated with a lubricous material, often a material such as PTFE, hydrophilic material or parylene, preferably PTFE. - In one embodiment, illustrated in
FIGS. 15 a-15 c, thesheath 74 contains aninflatable balloon 77 at the distal end and means for inflating theballoon 75, such as an inflation lumen. Theballoon 77 is in a deflated position as theneedle 44 crosses the fossa ovalis. In one embodiment, illustrated inFIG. 15 b, theballoon 77 is disposed around theneedle 44, and theballoon 77 is inflated as it crosses the fossa ovalis, thereby enlarging the puncture made by theneedle 44. This embodiment may be used with or without anadditional dilator 20 as described herein. If desired, theballoon 77 may be deflated and withdrawn after thesheath 74 has accessed the left atrium. Alternatively, the balloon may be left inflated, or further inflated after thesheath 74 accesses the left atrium. In another embodiment, as illustrated inFIG. 15 c, theballoon 77 may be inflated after the balloon crosses the fossa ovalis. In those embodiments where theballoon 77 remains in an inflated position after thesheath 74 crosses the fossa ovalis, theinflated balloon 77 creates an atraumatic distal tip that can be navigated to access a location of interest, such as the LAA. In those embodiments where theballoon 77 is inflated to a diameter greater than the diameter of thesheath 74, the balloon prevents the sheath from unintentionally passing back through the fossa ovalis during subsequent procedures. - In another embodiment, illustrated in
FIG. 17A , at least a portion of theneedle 44, thedilator 20 and at least a distal portion of thesheath 74 are encompassed by a thin-walled jacket 82 that is made of lubricous material, preferably PTFE. As illustrated inFIG. 17B , the distal end of thejacket 82 advances across thefossa ovalis 72 with theneedle 44. As illustrated inFIG. 17C , thedilator 20 andsheath 74 then cross thefossa ovalis 72 within thejacket 82. Preferably the jacket is radially enlargeable and may have a thickness in the range of about 0.05 mm to about 0.75 mm depending upon the construction material. The optimum material or combination of materials for coating theneedle 44, coating thedilator 20, or forming thejacket 82 can be determined for any particular application through routine experimentation by one or ordinary skill in the art based on the disclosures herein. - In another embodiment, illustrated in
FIG. 18 , thesheath 74 is itself tapered at its distal end to encompass at least a portion of the dilator. In this embodiment thesheath 74 is preferably tapered to encompass the dilator and at least a portion of theneedle 44. In another embodiment, illustrated inFIG. 19 , thesheath 74 includes means, such as a vacuum lumen, for applying avacuum 83 at the distal end. The vacuum lumen may be concentrically disposed within theneedle 44 and thedilator 20, concentrically disposed within thedilator 20, but side by side with theneedle 44, or side by side with thedilator 20. In one embodiment the vacuum is applied to the fossa ovalis before theneedle 44 punctures the fossa ovalis. Alternatively, the vacuum is applied to the fossa ovalis after the needle punctures the fossa ovalis and before or as thedilator 20 crosses the fossa ovalis. The vacuum maintains the position of the fossa ovalis and reduces “tenting” during the transseptal access procedure. Alternatively the vacuum may draw the fossa ovalis into thesheath 74. In yet another embodiment, which one or ordinary skill in the art will appreciate may be used in conjunction with many of the embodiments described above, theneedle 44 is oscillated at ultrasonic frequencies to further reduce friction between theneedle 44 and thefossa ovalis 72. - Although the present invention has been described in terms of certain preferred embodiments, other embodiments will become apparent to those of skill in the art in view of the disclosure herein. Accordingly, the scope of the present invention is not intended to be limited by the specific embodiments disclosed herein, but, rather, by the full scope of the claims attached below.
Claims (12)
1. A transseptal access system, comprising a sheath, a dilator and a needle; wherein the sheath comprises:
a first curved section shaped to abut an interior wall of a right atrium substantially opposite a septum between a right atrial appendage and a left atrial appendage and directed toward the septum;
the first curved section having an outer edge that defines a first proximal edge point, and a first distal edge point wherein the intersection between a tan ent drawn to the first curved section at the first proximal edge point and a tangent drawn to the first curved section at the first distal edge point, define a first angle and a first plane,
wherein the first angle is within the range of about 75 degrees to about 105 degrees,
wherein the needle is adapted to penetrate a fossa ovalis when the distal end of the dilator is advanced to contact the fossa ovalis,
further wherein the needle comprises one or more radially extensible blades adapted to be extended radially within the left atrium following penetration of the fossa ovalis by the needle such that the radially extended blades are adapted to expand the size of penetration of the fossa ovalis when the needle and one or more radially extended blades are withdrawn through the penetration of the fossa ovalis.
2. The transseptal access system of claim 1 , further comprising:
a second curved section shaped to direct a distal end of the sheath toward a left atrial appendage;
the second curved section having an outer edge that defines a second proximal edge point, and a second distal edge point wherein the intersection between a tangent drawn to the second curved section at the second proximal edge point and a tangent drawn to the second curved section at the second distal edge point, define a second angle and a second plane,
wherein the angle between the first and second plane, defined as the acute angle between the normal to the first plane and the normal to the second plane, is within the range of about 75 degrees to about 105 degrees.
3. The transseptal access system of claim 1 , wherein the first angle is within the range of about 80 degrees to about 100 degrees.
4. The transseptal access system of claim 2 , wherein the second angle is within the range of about 80 degrees to about 100 degrees.
5. The transseptal access system of claim 1 , wherein the dilator comprises an inflatable balloon.
6. The transseptal access system of claim 1 , wherein the dilator is coated with PTFE.
7. The transseptal access system of claim 1 , wherein the needle is advanced by a biasing means.
8. The transseptal access system of claim 1 , wherein the dilator comprises a vacuum lumen to allow application of a vacuum to the fossa ovalis.
9. The transseptal access system of claim 1 , wherein the dilator includes at least one infusion port for infusing saline solution.
10. The transseptal access system of claim 1 , wherein the sheath comprises a vacuum lumen to allow application of a vacuum to the fossa ovalis.
11. The transseptal access system of claim 1 , wherein the sheath comprises a vacuum lumen to allow application of a vacuum to the fossa ovalis.
12. The transseptal access system of claim 1 , further comprising an ultrasound transducer for oscillating the needle at ultrasonic frequencies.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/834,499 US20150359563A1 (en) | 2000-04-13 | 2015-08-25 | Method and apparatus for accessing the left atrial appendage |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/549,218 US6650923B1 (en) | 2000-04-13 | 2000-04-13 | Method for accessing the left atrium of the heart by locating the fossa ovalis |
US10/100,270 US7056294B2 (en) | 2000-04-13 | 2002-03-15 | Method and apparatus for accessing the left atrial appendage |
US11/228,988 US9131849B2 (en) | 2000-04-13 | 2005-09-16 | Method and apparatus for accessing the left atrial appendage |
US14/834,499 US20150359563A1 (en) | 2000-04-13 | 2015-08-25 | Method and apparatus for accessing the left atrial appendage |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/228,988 Continuation US9131849B2 (en) | 2000-04-13 | 2005-09-16 | Method and apparatus for accessing the left atrial appendage |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150359563A1 true US20150359563A1 (en) | 2015-12-17 |
Family
ID=28039764
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/100,270 Expired - Lifetime US7056294B2 (en) | 2000-04-13 | 2002-03-15 | Method and apparatus for accessing the left atrial appendage |
US11/228,988 Expired - Lifetime US9131849B2 (en) | 2000-04-13 | 2005-09-16 | Method and apparatus for accessing the left atrial appendage |
US14/834,499 Abandoned US20150359563A1 (en) | 2000-04-13 | 2015-08-25 | Method and apparatus for accessing the left atrial appendage |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/100,270 Expired - Lifetime US7056294B2 (en) | 2000-04-13 | 2002-03-15 | Method and apparatus for accessing the left atrial appendage |
US11/228,988 Expired - Lifetime US9131849B2 (en) | 2000-04-13 | 2005-09-16 | Method and apparatus for accessing the left atrial appendage |
Country Status (3)
Country | Link |
---|---|
US (3) | US7056294B2 (en) |
AU (1) | AU2003225822A1 (en) |
WO (1) | WO2003077733A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10383610B2 (en) | 2017-10-27 | 2019-08-20 | Intuitap Medical, Inc. | Tactile sensing and needle guidance device |
US11179097B2 (en) | 2016-05-03 | 2021-11-23 | Texas Medical Center | Tactile sensing device for lumbar punctures |
Families Citing this family (387)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6379334B1 (en) | 1997-02-10 | 2002-04-30 | Essex Technology, Inc. | Rotate advance catheterization system |
US7128073B1 (en) | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
US8506519B2 (en) | 1999-02-16 | 2013-08-13 | Flowcardia, Inc. | Pre-shaped therapeutic catheter |
US6855123B2 (en) | 2002-08-02 | 2005-02-15 | Flow Cardia, Inc. | Therapeutic ultrasound system |
US6488689B1 (en) | 1999-05-20 | 2002-12-03 | Aaron V. Kaplan | Methods and apparatus for transpericardial left atrial appendage closure |
WO2001023027A1 (en) | 1999-09-27 | 2001-04-05 | Essex Technology, Inc. | Rotate-to-advance catheterization system |
US20050148925A1 (en) * | 2001-04-20 | 2005-07-07 | Dan Rottenberg | Device and method for controlling in-vivo pressure |
US8091556B2 (en) | 2001-04-20 | 2012-01-10 | V-Wave Ltd. | Methods and apparatus for reducing localized circulatory system pressure |
US20080114394A1 (en) | 2001-04-24 | 2008-05-15 | Houser Russell A | Arteriotomy Closure Devices and Techniques |
US8961541B2 (en) | 2007-12-03 | 2015-02-24 | Cardio Vascular Technologies Inc. | Vascular closure devices, systems, and methods of use |
US20090143808A1 (en) * | 2001-04-24 | 2009-06-04 | Houser Russell A | Guided Tissue Cutting Device, Method of Use and Kits Therefor |
US8992567B1 (en) | 2001-04-24 | 2015-03-31 | Cardiovascular Technologies Inc. | Compressible, deformable, or deflectable tissue closure devices and method of manufacture |
US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US20060052821A1 (en) | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
JP4287273B2 (en) | 2001-09-24 | 2009-07-01 | アプライド メディカル リソーシーズ コーポレイション | Bladeless obturator |
US10098640B2 (en) | 2001-12-04 | 2018-10-16 | Atricure, Inc. | Left atrial appendage devices and methods |
WO2003053493A2 (en) | 2001-12-19 | 2003-07-03 | Nmt Medical, Inc. | Septal occluder and associated methods |
US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
WO2003082076A2 (en) | 2002-03-25 | 2003-10-09 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure clips |
WO2003096879A2 (en) | 2002-05-16 | 2003-11-27 | Applied Medical Resources Corporation | Cone tip obturator |
JP2005528162A (en) | 2002-06-03 | 2005-09-22 | エヌエムティー メディカル インコーポレイテッド | Device with biological tissue scaffold for intracardiac defect occlusion |
WO2003103476A2 (en) | 2002-06-05 | 2003-12-18 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure device with radial and circumferential support |
US9955994B2 (en) | 2002-08-02 | 2018-05-01 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US8133236B2 (en) | 2006-11-07 | 2012-03-13 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US7070582B2 (en) * | 2002-08-09 | 2006-07-04 | Boston Scientific Scimed, Inc. | Injection devices that provide reduced outflow of therapeutic agents and methods of delivering therapeutic agents |
JP4511935B2 (en) * | 2002-08-24 | 2010-07-28 | サブラマニアム シー. クリシュナン | Transseptal puncture device |
US6942677B2 (en) | 2003-02-26 | 2005-09-13 | Flowcardia, Inc. | Ultrasound catheter apparatus |
US7137963B2 (en) | 2002-08-26 | 2006-11-21 | Flowcardia, Inc. | Ultrasound catheter for disrupting blood vessel obstructions |
US7604608B2 (en) * | 2003-01-14 | 2009-10-20 | Flowcardia, Inc. | Ultrasound catheter and methods for making and using same |
US7335180B2 (en) | 2003-11-24 | 2008-02-26 | Flowcardia, Inc. | Steerable ultrasound catheter |
US7220233B2 (en) | 2003-04-08 | 2007-05-22 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
CA2498880A1 (en) * | 2002-09-23 | 2004-04-01 | Nmt Medical, Inc. | Loader for prosthetic occluders and methods thereof |
WO2004037333A1 (en) | 2002-10-25 | 2004-05-06 | Nmt Medical, Inc. | Expandable sheath tubing |
WO2004052213A1 (en) | 2002-12-09 | 2004-06-24 | Nmt Medical, Inc. | Septal closure devices |
US7048733B2 (en) * | 2003-09-19 | 2006-05-23 | Baylis Medical Company Inc. | Surgical perforation device with curve |
US11039880B2 (en) * | 2003-01-21 | 2021-06-22 | Baylis Medical Company Inc. | Method of surgical perforation via the delivery of energy |
US9597146B2 (en) * | 2003-01-21 | 2017-03-21 | Baylis Medical Company Inc. | Method of surgical perforation via the delivery of energy |
US7112197B2 (en) * | 2003-01-21 | 2006-09-26 | Baylis Medical Company Inc. | Surgical device with pressure monitoring ability |
US7270662B2 (en) * | 2004-01-21 | 2007-09-18 | Naheed Visram | Surgical perforation device with electrocardiogram (ECG) monitoring ability and method of using ECG to position a surgical perforation device |
US7947040B2 (en) * | 2003-01-21 | 2011-05-24 | Baylis Medical Company Inc | Method of surgical perforation via the delivery of energy |
US20040143262A1 (en) * | 2003-01-21 | 2004-07-22 | Baylis Medical Company Inc. | Surgical perforation device and method with pressure monitoring and staining abilities |
US8021359B2 (en) | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
US7658747B2 (en) | 2003-03-12 | 2010-02-09 | Nmt Medical, Inc. | Medical device for manipulation of a medical implant |
US7497857B2 (en) | 2003-04-29 | 2009-03-03 | Medtronic, Inc. | Endocardial dispersive electrode for use with a monopolar RF ablation pen |
US8021387B2 (en) * | 2003-07-11 | 2011-09-20 | Biosense Webster, Inc. | Trans-septal sheath with splitting dilating needle and method for its use |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US7678123B2 (en) | 2003-07-14 | 2010-03-16 | Nmt Medical, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
DE602004017750D1 (en) | 2003-08-19 | 2008-12-24 | Nmt Medical Inc | Expandable lock hose |
WO2005034763A1 (en) | 2003-09-11 | 2005-04-21 | Nmt Medical, Inc. | Devices, systems, and methods for suturing tissue |
US7758510B2 (en) | 2003-09-19 | 2010-07-20 | Flowcardia, Inc. | Connector for securing ultrasound catheter to transducer |
WO2005030089A2 (en) * | 2003-09-26 | 2005-04-07 | Handsen Medical, Inc. | Left atrial access apparatus and methods |
EP2543329B1 (en) | 2003-10-03 | 2014-02-12 | Applied Medical Resources Corporation | Bladeless optical obturator |
EP1682034B1 (en) | 2003-10-09 | 2018-11-21 | Sentreheart, Inc. | Apparatus for the ligation of tissue |
JP4496223B2 (en) | 2003-11-06 | 2010-07-07 | エヌエムティー メディカル, インコーポレイティッド | Septal penetration device |
US8292910B2 (en) | 2003-11-06 | 2012-10-23 | Pressure Products Medical Supplies, Inc. | Transseptal puncture apparatus |
US20050273119A1 (en) | 2003-12-09 | 2005-12-08 | Nmt Medical, Inc. | Double spiral patent foramen ovale closure clamp |
US20050149097A1 (en) * | 2003-12-30 | 2005-07-07 | Regnell Sandra J. | Transseptal needle |
US20050192626A1 (en) | 2004-01-30 | 2005-09-01 | Nmt Medical, Inc. | Devices, systems, and methods for closure of cardiac openings |
JP2007519498A (en) | 2004-01-30 | 2007-07-19 | エヌエムティー メディカル, インコーポレイティッド | Devices, systems, and methods for closure of cardiac openings |
US7871419B2 (en) | 2004-03-03 | 2011-01-18 | Nmt Medical, Inc. | Delivery/recovery system for septal occluder |
US20050267524A1 (en) | 2004-04-09 | 2005-12-01 | Nmt Medical, Inc. | Split ends closure device |
US8361110B2 (en) | 2004-04-26 | 2013-01-29 | W.L. Gore & Associates, Inc. | Heart-shaped PFO closure device |
US7842053B2 (en) | 2004-05-06 | 2010-11-30 | Nmt Medical, Inc. | Double coil occluder |
US8308760B2 (en) | 2004-05-06 | 2012-11-13 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
JP2007535997A (en) | 2004-05-07 | 2007-12-13 | エヌエムティー メディカル, インコーポレイティッド | Capturing mechanism of tubular septal occluder |
US7704268B2 (en) | 2004-05-07 | 2010-04-27 | Nmt Medical, Inc. | Closure device with hinges |
US7645285B2 (en) | 2004-05-26 | 2010-01-12 | Idx Medical, Ltd | Apparatus and methods for occluding a hollow anatomical structure |
JP5178194B2 (en) * | 2004-06-14 | 2013-04-10 | ロックス メディカル, インコーポレイテッド | Devices, systems, and methods for arterio-venous fistula generation |
US8409219B2 (en) | 2004-06-18 | 2013-04-02 | Medtronic, Inc. | Method and system for placement of electrical lead inside heart |
AU2005260071B2 (en) * | 2004-06-29 | 2011-06-30 | Applied Medical Resources Corporation | Insufflating optical surgical instrument |
US7678081B2 (en) * | 2004-07-12 | 2010-03-16 | Pacesetter, Inc. | Methods and devices for transseptal access |
US7540852B2 (en) | 2004-08-26 | 2009-06-02 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
US20060135962A1 (en) * | 2004-09-09 | 2006-06-22 | Kick George F | Expandable trans-septal sheath |
WO2006036837A2 (en) | 2004-09-24 | 2006-04-06 | Nmt Medical, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
US20070083168A1 (en) * | 2004-09-30 | 2007-04-12 | Whiting James S | Transmembrane access systems and methods |
US8029470B2 (en) | 2004-09-30 | 2011-10-04 | Pacesetter, Inc. | Transmembrane access systems and methods |
US20060079787A1 (en) * | 2004-09-30 | 2006-04-13 | Whiting James S | Transmembrane access systems and methods |
US20060095100A1 (en) * | 2004-10-29 | 2006-05-04 | Kian Shin Lee | Method and apparatus for regulating light administered at a patient treatment site |
JP4709584B2 (en) * | 2004-12-24 | 2011-06-22 | 富士フイルム株式会社 | Ultrasonic diagnostic apparatus, ultrasonic tomographic image generation method, and ultrasonic tomographic image generation program |
US8221343B2 (en) | 2005-01-20 | 2012-07-17 | Flowcardia, Inc. | Vibrational catheter devices and methods for making same |
US7930016B1 (en) | 2005-02-02 | 2011-04-19 | Voyage Medical, Inc. | Tissue closure system |
US7860555B2 (en) * | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue visualization and manipulation system |
US8934962B2 (en) | 2005-02-02 | 2015-01-13 | Intuitive Surgical Operations, Inc. | Electrophysiology mapping and visualization system |
US7860556B2 (en) * | 2005-02-02 | 2010-12-28 | Voyage Medical, Inc. | Tissue imaging and extraction systems |
US10064540B2 (en) | 2005-02-02 | 2018-09-04 | Intuitive Surgical Operations, Inc. | Visualization apparatus for transseptal access |
US8050746B2 (en) | 2005-02-02 | 2011-11-01 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US20080015569A1 (en) | 2005-02-02 | 2008-01-17 | Voyage Medical, Inc. | Methods and apparatus for treatment of atrial fibrillation |
US7918787B2 (en) * | 2005-02-02 | 2011-04-05 | Voyage Medical, Inc. | Tissue visualization and manipulation systems |
US8137333B2 (en) | 2005-10-25 | 2012-03-20 | Voyage Medical, Inc. | Delivery of biological compounds to ischemic and/or infarcted tissue |
US9510732B2 (en) | 2005-10-25 | 2016-12-06 | Intuitive Surgical Operations, Inc. | Methods and apparatus for efficient purging |
US11478152B2 (en) | 2005-02-02 | 2022-10-25 | Intuitive Surgical Operations, Inc. | Electrophysiology mapping and visualization system |
US8078266B2 (en) | 2005-10-25 | 2011-12-13 | Voyage Medical, Inc. | Flow reduction hood systems |
WO2006093976A1 (en) | 2005-02-28 | 2006-09-08 | Spirus Medical Inc. | Rotate-to-advance catheterization system |
DE602006019063D1 (en) | 2005-03-03 | 2011-02-03 | Atrial Fibrillation Division Inc | DEVICE FOR CONSTRUCTING THE FOSSA OVALIS BY PRODUCTION OF A VIRTUAL FOSSA OVALIS AND PERFORMANCE OF A TRANSSEPTAL POINT |
EP1868507A1 (en) | 2005-03-18 | 2007-12-26 | NMT Medical, Inc. | Catch member for pfo occluder |
US7918865B2 (en) | 2005-04-07 | 2011-04-05 | Sentreheart, Inc. | Apparatus and method for the ligation of tissue |
US8317678B2 (en) | 2005-05-04 | 2012-11-27 | Olympus Endo Technology America Inc. | Rotate-to-advance catheterization system |
US8235942B2 (en) | 2005-05-04 | 2012-08-07 | Olympus Endo Technology America Inc. | Rotate-to-advance catheterization system |
US7780650B2 (en) | 2005-05-04 | 2010-08-24 | Spirus Medical, Inc. | Rotate-to-advance catheterization system |
US8343040B2 (en) | 2005-05-04 | 2013-01-01 | Olympus Endo Technology America Inc. | Rotate-to-advance catheterization system |
US8414477B2 (en) | 2005-05-04 | 2013-04-09 | Olympus Endo Technology America Inc. | Rotate-to-advance catheterization system |
US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
EP1906842B1 (en) | 2005-07-14 | 2016-12-21 | IDX Medical, Ltd. | Apparatus for occluding a hollow anatomical structure |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
US9259267B2 (en) | 2005-09-06 | 2016-02-16 | W.L. Gore & Associates, Inc. | Devices and methods for treating cardiac tissue |
US20070093804A1 (en) * | 2005-10-17 | 2007-04-26 | Coaptus Medical Corporation | Control systems for patient devices, including devices for securing cardiovascular tissue, and associated methods |
US8221310B2 (en) | 2005-10-25 | 2012-07-17 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US8449606B2 (en) | 2005-10-26 | 2013-05-28 | Cardiosolutions, Inc. | Balloon mitral spacer |
US8216302B2 (en) | 2005-10-26 | 2012-07-10 | Cardiosolutions, Inc. | Implant delivery and deployment system and method |
US8092525B2 (en) | 2005-10-26 | 2012-01-10 | Cardiosolutions, Inc. | Heart valve implant |
US8778017B2 (en) * | 2005-10-26 | 2014-07-15 | Cardiosolutions, Inc. | Safety for mitral valve implant |
US7785366B2 (en) | 2005-10-26 | 2010-08-31 | Maurer Christopher W | Mitral spacer |
US9259317B2 (en) * | 2008-06-13 | 2016-02-16 | Cardiosolutions, Inc. | System and method for implanting a heart implant |
US8852270B2 (en) | 2007-11-15 | 2014-10-07 | Cardiosolutions, Inc. | Implant delivery system and method |
US8052715B2 (en) * | 2005-12-01 | 2011-11-08 | Atritech, Inc. | Method and apparatus for recapturing an implant from the left atrial appendage |
US8142470B2 (en) | 2005-12-01 | 2012-03-27 | Atritech, Inc. | Method for accessing the left atrial appendage with a balloon-tipped transeptal sheath |
WO2007073566A1 (en) | 2005-12-22 | 2007-06-28 | Nmt Medical, Inc. | Catch members for occluder devices |
DE102005062657A1 (en) * | 2005-12-28 | 2007-07-12 | Osypka, Peter, Dr.-Ing. | Device for closing an opening located in a heart separation wall |
US9681948B2 (en) | 2006-01-23 | 2017-06-20 | V-Wave Ltd. | Heart anchor device |
US8574220B2 (en) | 2006-02-28 | 2013-11-05 | Olympus Endo Technology America Inc. | Rotate-to-advance catheterization system |
US8435229B2 (en) | 2006-02-28 | 2013-05-07 | Olympus Endo Technology America Inc. | Rotate-to-advance catheterization system |
JP2009532125A (en) | 2006-03-31 | 2009-09-10 | エヌエムティー メディカル, インコーポレイティッド | Deformable flap catch mechanism for occluder equipment |
US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
US8551135B2 (en) | 2006-03-31 | 2013-10-08 | W.L. Gore & Associates, Inc. | Screw catch mechanism for PFO occluder and method of use |
US9282984B2 (en) | 2006-04-05 | 2016-03-15 | Flowcardia, Inc. | Therapeutic ultrasound system |
JP2009534148A (en) * | 2006-04-26 | 2009-09-24 | ノボ・ノルデイスク・エー/エス | Cannula for infusion device having tapered end and method for manufacturing the cannula |
US9511214B2 (en) | 2006-05-02 | 2016-12-06 | Vascular Access Technologies, Inc. | Methods of transvascular retrograde access placement and devices for facilitating therein |
WO2007128064A1 (en) * | 2006-05-08 | 2007-11-15 | Cathrx Ltd | Shape imparting mechanism insertion |
US20070282254A1 (en) * | 2006-05-16 | 2007-12-06 | Mina Chow | Needle devices and methods |
US20070270741A1 (en) * | 2006-05-17 | 2007-11-22 | Hassett James A | Transseptal needle assembly and methods |
US9055906B2 (en) | 2006-06-14 | 2015-06-16 | Intuitive Surgical Operations, Inc. | In-vivo visualization systems |
EP2049184B1 (en) * | 2006-07-26 | 2013-02-13 | Johan Willem Pieter Marsman | Facilitation of antegrade insertion of a guidewire into the superficial femoral artery |
US20080033241A1 (en) * | 2006-08-01 | 2008-02-07 | Ruey-Feng Peh | Left atrial appendage closure |
US10004388B2 (en) | 2006-09-01 | 2018-06-26 | Intuitive Surgical Operations, Inc. | Coronary sinus cannulation |
US20080097476A1 (en) | 2006-09-01 | 2008-04-24 | Voyage Medical, Inc. | Precision control systems for tissue visualization and manipulation assemblies |
US11666377B2 (en) | 2006-09-29 | 2023-06-06 | Boston Scientific Medical Device Limited | Electrosurgical device |
US20210121227A1 (en) | 2006-09-29 | 2021-04-29 | Baylis Medical Company Inc. | Connector system for electrosurgical device |
EP3581116A1 (en) | 2006-10-06 | 2019-12-18 | Applied Medical Resources Corporation | Visual insufflation port |
US10335131B2 (en) * | 2006-10-23 | 2019-07-02 | Intuitive Surgical Operations, Inc. | Methods for preventing tissue migration |
US9232997B2 (en) | 2006-11-07 | 2016-01-12 | Corvia Medical, Inc. | Devices and methods for retrievable intra-atrial implants |
US20110257723A1 (en) | 2006-11-07 | 2011-10-20 | Dc Devices, Inc. | Devices and methods for coronary sinus pressure relief |
US10624621B2 (en) | 2006-11-07 | 2020-04-21 | Corvia Medical, Inc. | Devices and methods for the treatment of heart failure |
US8460372B2 (en) | 2006-11-07 | 2013-06-11 | Dc Devices, Inc. | Prosthesis for reducing intra-cardiac pressure having an embolic filter |
US8246643B2 (en) | 2006-11-07 | 2012-08-21 | Flowcardia, Inc. | Ultrasound catheter having improved distal end |
US10413284B2 (en) | 2006-11-07 | 2019-09-17 | Corvia Medical, Inc. | Atrial pressure regulation with control, sensing, monitoring and therapy delivery |
US20080183036A1 (en) | 2006-12-18 | 2008-07-31 | Voyage Medical, Inc. | Systems and methods for unobstructed visualization and ablation |
US8337518B2 (en) * | 2006-12-20 | 2012-12-25 | Onset Medical Corporation | Expandable trans-septal sheath |
US8131350B2 (en) | 2006-12-21 | 2012-03-06 | Voyage Medical, Inc. | Stabilization of visualization catheters |
US8758229B2 (en) | 2006-12-21 | 2014-06-24 | Intuitive Surgical Operations, Inc. | Axial visualization systems |
US8473030B2 (en) * | 2007-01-12 | 2013-06-25 | Medtronic Vascular, Inc. | Vessel position and configuration imaging apparatus and methods |
EP2574287B1 (en) | 2007-03-30 | 2015-04-22 | Sentreheart, Inc. | Devices for closing the left atrial appendage |
US20080243141A1 (en) | 2007-04-02 | 2008-10-02 | Salvatore Privitera | Surgical instrument with separate tool head and method of use |
US9005242B2 (en) | 2007-04-05 | 2015-04-14 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
WO2008131167A1 (en) | 2007-04-18 | 2008-10-30 | Nmt Medical, Inc. | Flexible catheter system |
US9050064B2 (en) * | 2007-04-27 | 2015-06-09 | Cvdevices, Llc | Systems for engaging a bodily tissue and methods of using the same |
EP2148608A4 (en) | 2007-04-27 | 2010-04-28 | Voyage Medical Inc | Complex shape steerable tissue visualization and manipulation catheter |
US8657805B2 (en) | 2007-05-08 | 2014-02-25 | Intuitive Surgical Operations, Inc. | Complex shape steerable tissue visualization and manipulation catheter |
EP3025636B1 (en) | 2007-05-11 | 2017-11-01 | Intuitive Surgical Operations, Inc. | Visual electrode ablation systems |
US8870755B2 (en) | 2007-05-18 | 2014-10-28 | Olympus Endo Technology America Inc. | Rotate-to-advance catheterization system |
WO2008152617A2 (en) | 2007-06-15 | 2008-12-18 | Zerusa Limited | A closure device |
US20090030276A1 (en) * | 2007-07-27 | 2009-01-29 | Voyage Medical, Inc. | Tissue visualization catheter with imaging systems integration |
US8235985B2 (en) | 2007-08-31 | 2012-08-07 | Voyage Medical, Inc. | Visualization and ablation system variations |
US20090062790A1 (en) * | 2007-08-31 | 2009-03-05 | Voyage Medical, Inc. | Direct visualization bipolar ablation systems |
EP2214563B1 (en) | 2007-09-20 | 2017-04-19 | Sentreheart, Inc. | Devices and methods for remote suture management |
WO2009052432A2 (en) | 2007-10-19 | 2009-04-23 | Coherex Medical, Inc. | Medical device for modification of left atrial appendange and related systems and methods |
US8500697B2 (en) * | 2007-10-19 | 2013-08-06 | Pressure Products Medical Supplies, Inc. | Transseptal guidewire |
US20090125022A1 (en) * | 2007-11-12 | 2009-05-14 | Voyage Medical, Inc. | Tissue visualization and ablation systems |
US20090143640A1 (en) * | 2007-11-26 | 2009-06-04 | Voyage Medical, Inc. | Combination imaging and treatment assemblies |
US20090156921A1 (en) * | 2007-12-18 | 2009-06-18 | Huisun Wang | Cardiac ablation catheter with oxygen saturation sensor |
US20090156916A1 (en) * | 2007-12-18 | 2009-06-18 | Huisun Wang | Catheter systems with blood measurement device and methods |
US8231927B2 (en) * | 2007-12-21 | 2012-07-31 | Innovatech, Llc | Marked precoated medical device and method of manufacturing same |
US7963947B2 (en) * | 2008-01-16 | 2011-06-21 | Pressure Products Medical Supplies, Inc. | Apparatus, system, and method of shielding the sharp tip of a transseptal guidewire |
EP2837343B1 (en) | 2008-01-25 | 2016-09-14 | Applied Medical Resources Corporation | Insufflating access system |
US8337425B2 (en) * | 2008-02-05 | 2012-12-25 | Bridgepoint Medical, Inc. | Endovascular device with a tissue piercing distal probe and associated methods |
US8858609B2 (en) | 2008-02-07 | 2014-10-14 | Intuitive Surgical Operations, Inc. | Stent delivery under direct visualization |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
US20110087261A1 (en) * | 2008-03-11 | 2011-04-14 | Umc Utrecht Holding B.V. | Device and Method for Transseptal Puncturing |
DK2268200T3 (en) | 2008-03-18 | 2019-01-07 | Circa Scient Llc | TEMPERATURE MEASURING EQUIPMENT WITH LARGE SURFACE AREA |
US9833149B2 (en) | 2008-03-18 | 2017-12-05 | Circa Scientific, Llc | Methods, apparatus and systems for facilitating introduction of shaped medical instruments into the body of a subject |
US8591460B2 (en) * | 2008-06-13 | 2013-11-26 | Cardiosolutions, Inc. | Steerable catheter and dilator and system and method for implanting a heart implant |
EP2135638B1 (en) * | 2008-06-20 | 2015-03-11 | Ela Medical | Preformed mandrel for guiding a probe in contact with the wall of the septum |
US20090326572A1 (en) * | 2008-06-27 | 2009-12-31 | Ruey-Feng Peh | Apparatus and methods for rapid tissue crossing |
US9101735B2 (en) | 2008-07-07 | 2015-08-11 | Intuitive Surgical Operations, Inc. | Catheter control systems |
WO2010037099A1 (en) * | 2008-09-29 | 2010-04-01 | Applied Medical Resources Corporation | First-entry trocar system |
US8333012B2 (en) | 2008-10-10 | 2012-12-18 | Voyage Medical, Inc. | Method of forming electrode placement and connection systems |
US8894643B2 (en) | 2008-10-10 | 2014-11-25 | Intuitive Surgical Operations, Inc. | Integral electrode placement and connection systems |
US9468364B2 (en) | 2008-11-14 | 2016-10-18 | Intuitive Surgical Operations, Inc. | Intravascular catheter with hood and image processing systems |
US8317810B2 (en) * | 2008-12-29 | 2012-11-27 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Tissue puncture assemblies and methods for puncturing tissue |
US8388549B2 (en) | 2008-12-29 | 2013-03-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Anatomical thermal sensing device and method |
US10046141B2 (en) * | 2008-12-30 | 2018-08-14 | Biosense Webster, Inc. | Deflectable sheath introducer |
WO2010081033A1 (en) | 2009-01-08 | 2010-07-15 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9393023B2 (en) | 2009-01-13 | 2016-07-19 | Atricure, Inc. | Apparatus and methods for deploying a clip to occlude an anatomical structure |
US8332641B2 (en) * | 2009-01-30 | 2012-12-11 | Freescale Semiconductor, Inc. | Authenticated debug access for field returns |
US20100234876A1 (en) * | 2009-03-10 | 2010-09-16 | Boston Scientific Scimed, Inc. | Apparatus and methods for recapturing an ablation balloon |
US9198664B2 (en) | 2009-04-01 | 2015-12-01 | Sentreheart, Inc. | Tissue ligation devices and controls therefor |
US20100256629A1 (en) * | 2009-04-06 | 2010-10-07 | Voyage Medical, Inc. | Methods and devices for treatment of the ostium |
JP5807970B2 (en) | 2009-04-09 | 2015-11-10 | カーディオバスキュラー テクノロジーズ、インク. | Tissue suturing device, transfer device and system, kit and method therefor |
EP2427143B1 (en) | 2009-05-04 | 2017-08-02 | V-Wave Ltd. | Device for regulating pressure in a heart chamber |
US10076403B1 (en) | 2009-05-04 | 2018-09-18 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US20210161637A1 (en) | 2009-05-04 | 2021-06-03 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US9034034B2 (en) | 2010-12-22 | 2015-05-19 | V-Wave Ltd. | Devices for reducing left atrial pressure, and methods of making and using same |
EP2440130A4 (en) | 2009-06-08 | 2015-06-03 | Mri Interventions Inc | Mri-guided surgical systems with proximity alerts |
US8226566B2 (en) | 2009-06-12 | 2012-07-24 | Flowcardia, Inc. | Device and method for vascular re-entry |
US8396532B2 (en) | 2009-06-16 | 2013-03-12 | MRI Interventions, Inc. | MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time |
US9693781B2 (en) | 2009-06-17 | 2017-07-04 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9883864B2 (en) * | 2009-06-17 | 2018-02-06 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10064628B2 (en) | 2009-06-17 | 2018-09-04 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10631969B2 (en) | 2009-06-17 | 2020-04-28 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9351716B2 (en) | 2009-06-17 | 2016-05-31 | Coherex Medical, Inc. | Medical device and delivery system for modification of left atrial appendage and methods thereof |
US9649115B2 (en) | 2009-06-17 | 2017-05-16 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9636094B2 (en) | 2009-06-22 | 2017-05-02 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
EP2275170B1 (en) * | 2009-07-15 | 2012-08-29 | Sorin CRM SAS | Assembly suitable for implantation in the coronary sinus, including a stimulation probe with anchoring screw |
EP2459265B1 (en) * | 2009-07-27 | 2013-05-29 | Robert Kipperman | Patent foramen ovale catheter |
US8409236B2 (en) * | 2009-08-21 | 2013-04-02 | Vascular Access Technologies, Inc. | Methods of transvascular retrograde access placement and devices for facilitating the placement |
US9757107B2 (en) | 2009-09-04 | 2017-09-12 | Corvia Medical, Inc. | Methods and devices for intra-atrial shunts having adjustable sizes |
US20110144576A1 (en) * | 2009-12-14 | 2011-06-16 | Voyage Medical, Inc. | Catheter orientation control system mechanisms |
US9339599B2 (en) | 2009-12-21 | 2016-05-17 | Sorin Group Usa, Inc. | Self-dilating cannula |
US20110152741A1 (en) * | 2009-12-21 | 2011-06-23 | Michael Banchieri | Cannula system |
US11357486B2 (en) | 2009-12-30 | 2022-06-14 | Vivasure Medical Limited | Closure system and uses thereof |
CA2785041A1 (en) | 2010-01-29 | 2011-08-04 | Dc Devices, Inc. | Devices and methods for reducing venous pressure |
US8369932B2 (en) | 2010-01-29 | 2013-02-05 | Medtronic Ablation Frontiers Llc | Optical methods of identifying the location of a medical device within a patient's body in order to locate the fossa ovalis for trans-septal procedures |
EP2528646A4 (en) | 2010-01-29 | 2017-06-28 | DC Devices, Inc. | Devices and systems for treating heart failure |
US8694071B2 (en) | 2010-02-12 | 2014-04-08 | Intuitive Surgical Operations, Inc. | Image stabilization techniques and methods |
US9814522B2 (en) | 2010-04-06 | 2017-11-14 | Intuitive Surgical Operations, Inc. | Apparatus and methods for ablation efficacy |
EP2558014A4 (en) | 2010-04-13 | 2017-11-29 | Sentreheart, Inc. | Methods and devices for treating atrial fibrillation |
US8454584B2 (en) | 2010-04-13 | 2013-06-04 | Cook Medical Technologies Llc | Medical anchor device |
US11419632B2 (en) | 2010-04-23 | 2022-08-23 | Mark D. Wieczorek, P.C. | Transseptal access device and method of use |
US8940008B2 (en) | 2010-04-23 | 2015-01-27 | Assist Medical Llc | Transseptal access device and method of use |
US20190282749A1 (en) | 2010-04-23 | 2019-09-19 | Mark D. Wieczorek | Transseptal access device and method of uses |
US10220134B2 (en) | 2010-04-23 | 2019-03-05 | Mark D. Wieczorek | Transseptal access device and method of use |
US8500768B2 (en) * | 2010-05-11 | 2013-08-06 | Cardiac Inventions Unlimited Inc. | Apparatus for safe performance of transseptal technique and placement and positioning of an ablation catheter |
US9744339B2 (en) | 2010-05-12 | 2017-08-29 | Circa Scientific, Llc | Apparatus for manually manipulating hollow organs |
USD901009S1 (en) * | 2010-05-12 | 2020-11-03 | Circa Scientific, Inc. | Apparatus for manipulating hollow organs |
EP2613821B1 (en) | 2010-09-07 | 2023-02-15 | Paul A. Spence | Cannula systems |
US9017349B2 (en) | 2010-10-27 | 2015-04-28 | Atricure, Inc. | Appendage clamp deployment assist device |
US9072872B2 (en) | 2010-10-29 | 2015-07-07 | Medtronic, Inc. | Telescoping catheter delivery system for left heart endocardial device placement |
US9066741B2 (en) | 2010-11-01 | 2015-06-30 | Atricure, Inc. | Robotic toolkit |
US8636754B2 (en) | 2010-11-11 | 2014-01-28 | Atricure, Inc. | Clip applicator |
EP2673038B1 (en) | 2011-02-10 | 2017-07-19 | Corvia Medical, Inc. | Apparatus to create and maintain an intra-atrial pressure relief opening |
US8591495B2 (en) | 2011-02-23 | 2013-11-26 | Fischell Innovations, Llc | Introducer sheath with thin-walled shaft |
US20120239069A1 (en) * | 2011-03-17 | 2012-09-20 | Medtronic, Inc. | Transseptal Puncturing Device |
US8795253B2 (en) | 2011-04-05 | 2014-08-05 | Sorin Group Italia S.R.L. | Bi-directional perfusion cannula |
WO2012151276A2 (en) | 2011-05-02 | 2012-11-08 | Applied Medical Resources Corporation | Low-profile surgical universal access port |
ES2723792T3 (en) | 2011-05-16 | 2019-09-02 | Vivasure Medical Ltd | Sheath dilator system |
US8535294B2 (en) | 2011-06-01 | 2013-09-17 | Fischell Innovations Llc | Carotid sheath with flexible distal section |
CN106974692B (en) | 2011-06-08 | 2021-06-01 | 森特里心脏股份有限公司 | Tissue ligation device and tensioning device therefor |
US9629715B2 (en) | 2011-07-28 | 2017-04-25 | V-Wave Ltd. | Devices for reducing left atrial pressure having biodegradable constriction, and methods of making and using same |
US11135054B2 (en) | 2011-07-28 | 2021-10-05 | V-Wave Ltd. | Interatrial shunts having biodegradable material, and methods of making and using same |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
EP2744426B1 (en) | 2011-08-15 | 2018-10-10 | AtriCure Inc. | Occlusion clip applicator |
WO2013067446A1 (en) * | 2011-11-04 | 2013-05-10 | Caymus Medical, Inc. | Systems and methods for percutaneous intravascular access and guidewire placement |
WO2013096965A1 (en) | 2011-12-22 | 2013-06-27 | Dc Devices, Inc. | Methods and devices for intra-atrial devices having selectable flow rates |
US8747428B2 (en) * | 2012-01-12 | 2014-06-10 | Fischell Innovations, Llc | Carotid sheath with entry and tracking rapid exchange dilators and method of use |
WO2013109269A1 (en) | 2012-01-18 | 2013-07-25 | Bard Peripheral Vascular, Inc. | Vascular re-entry device |
US9282973B2 (en) | 2012-01-20 | 2016-03-15 | Atricure, Inc. | Clip deployment tool and associated methods |
US9005155B2 (en) | 2012-02-03 | 2015-04-14 | Dc Devices, Inc. | Devices and methods for treating heart failure |
US9737286B2 (en) | 2012-02-29 | 2017-08-22 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
US9821145B2 (en) | 2012-03-23 | 2017-11-21 | Pressure Products Medical Supplies Inc. | Transseptal puncture apparatus and method for using the same |
US10588611B2 (en) | 2012-04-19 | 2020-03-17 | Corvia Medical Inc. | Implant retention attachment and method of use |
US20130317542A1 (en) * | 2012-05-25 | 2013-11-28 | Boston Scientific Scimed, Inc. | Steerable delivery system |
US9623217B2 (en) | 2012-05-30 | 2017-04-18 | Vascular Access Techonlogies, Inc. | Transvascular access methods |
US9220874B2 (en) | 2012-05-30 | 2015-12-29 | Vascular Access Technologies, Inc. | Transvascular access device and method |
JP6416084B2 (en) | 2012-05-31 | 2018-10-31 | ベイリス メディカル カンパニー インコーポレイテッドBaylis Medical Company Inc. | Medical equipment |
US9233015B2 (en) | 2012-06-15 | 2016-01-12 | Trivascular, Inc. | Endovascular delivery system with an improved radiopaque marker scheme |
GB2503668B (en) * | 2012-07-03 | 2018-02-07 | Univ Hospitals Of Leicester Nhs Trust | Delivery apparatus |
US9649480B2 (en) | 2012-07-06 | 2017-05-16 | Corvia Medical, Inc. | Devices and methods of treating or ameliorating diastolic heart failure through pulmonary valve intervention |
EP3895632A1 (en) | 2012-08-02 | 2021-10-20 | Bard Peripheral Vascular, Inc. | Ultrasound catheter system |
US10179009B2 (en) | 2012-08-07 | 2019-01-15 | Ahmad Abdul-Karim | Needleless transseptal access device and methods |
EP2908880B1 (en) | 2012-10-16 | 2018-12-05 | Paul A. Spence | Devices for facilitating flow from the heart to a blood pump |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
US9775636B2 (en) | 2013-03-12 | 2017-10-03 | Corvia Medical, Inc. | Devices, systems, and methods for treating heart failure |
US11937873B2 (en) | 2013-03-12 | 2024-03-26 | Boston Scientific Medical Device Limited | Electrosurgical device having a lumen |
CA2902064C (en) | 2013-03-12 | 2021-06-01 | Sentreheart, Inc. | Tissue ligation devices and methods therefor |
US10617425B2 (en) | 2014-03-10 | 2020-04-14 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US11399842B2 (en) | 2013-03-13 | 2022-08-02 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
CN105246540A (en) | 2013-03-13 | 2016-01-13 | 阿龙·V·卡普兰 | Devices and methods for excluding left atrial appendage |
US9289297B2 (en) | 2013-03-15 | 2016-03-22 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US20140277054A1 (en) * | 2013-03-15 | 2014-09-18 | Dc Devices, Inc. | Devices, systems, and methods for percutaneous trans-septal puncture |
US9232998B2 (en) | 2013-03-15 | 2016-01-12 | Cardiosolutions Inc. | Trans-apical implant systems, implants and methods |
US9850013B2 (en) | 2013-03-15 | 2017-12-26 | Vivasure Medical Limited | Loading devices and methods for percutaneous perforation closure systems |
US9700351B2 (en) | 2013-04-15 | 2017-07-11 | Transseptal Solutions Ltd. | Fossa ovalis penetration |
US9788858B2 (en) | 2013-04-15 | 2017-10-17 | Transseptal Solutions Ltd. | Fossa ovalis penetration using probing elements |
US9545265B2 (en) | 2013-04-15 | 2017-01-17 | Transseptal Solutions Ltd. | Fossa ovalis penetration using balloons |
US20140336572A1 (en) | 2013-05-07 | 2014-11-13 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Guiding Medical Devices and Associated Methods of Manufacturing |
WO2014182797A1 (en) * | 2013-05-07 | 2014-11-13 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Steerable medical device having multiple curve profiles |
EP2999412B1 (en) | 2013-05-21 | 2020-05-06 | V-Wave Ltd. | Apparatus for delivering devices for reducing left atrial pressure |
AU2014268717A1 (en) | 2013-05-24 | 2015-12-03 | Bioventrix, Inc. | Cardiac tissue penetrating devices, methods, and systems for treatment of congestive heart failure and other conditions |
AU2014277902A1 (en) | 2013-06-14 | 2016-02-04 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
FR3006884B1 (en) * | 2013-06-18 | 2016-06-24 | Laboratoires Invalv | ATRAUMATIC DEVICE FOR INTRODUCING A HOLLOW TUBULAR ELEMENT IN A BIOLOGICAL ORGAN |
CA3117171C (en) | 2013-08-07 | 2024-02-20 | Baylis Medical Company Inc. | Methods and devices for puncturing tissue |
US10471241B2 (en) | 2013-08-26 | 2019-11-12 | Merit Medical Systems, Inc. | Sheathless guide, rapid exchange dilator and associated methods |
WO2015042368A2 (en) * | 2013-09-19 | 2015-03-26 | W.L. Gore & Associates, Inc. | Dilator systems and methods |
WO2015066549A1 (en) | 2013-10-31 | 2015-05-07 | Sentreheart, Inc. | Devices and methods for left atrial appendage closure |
US9808283B2 (en) | 2013-12-04 | 2017-11-07 | Heartware, Inc. | Apparatus and methods for cutting an atrial wall |
US10675450B2 (en) | 2014-03-12 | 2020-06-09 | Corvia Medical, Inc. | Devices and methods for treating heart failure |
EP3116407B1 (en) * | 2014-03-14 | 2021-05-19 | Cardiac Assist, Inc. | Image-guided transseptal puncture device |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9814483B2 (en) * | 2014-06-13 | 2017-11-14 | InterShunt Technologies, Inc. | Method and catheter for creating an interatrial aperture |
US20160270810A1 (en) * | 2014-06-13 | 2016-09-22 | InterShunt Technologies, Inc. | Method and catheter for creating an interatrial aperture |
US10993735B2 (en) | 2014-06-13 | 2021-05-04 | InterShunt Technologies, Inc. | Method and catheter for creating an interatrial aperture |
US11369405B2 (en) | 2014-06-13 | 2022-06-28 | InterShunt Technologies, Inc. | Method and septostomy device for creating an interatrial aperture |
JP6799526B2 (en) | 2014-07-23 | 2020-12-16 | コルヴィア メディカル インコーポレイテッド | Equipment and methods for the treatment of heart failure |
EP3206603B1 (en) | 2014-10-14 | 2019-10-02 | Transseptal Solutions Ltd. | Fossa ovalis penetration apparatus |
WO2016096932A1 (en) | 2014-12-15 | 2016-06-23 | Vivasure Medical Limited | Closure apparatus with flexible sealable member and flexible support member |
EP3232939B1 (en) | 2014-12-15 | 2020-09-23 | Vivasure Medical Limited | Implantable sealable member with mesh layer |
EP4241820A1 (en) * | 2015-01-23 | 2023-09-13 | Terumo Kabushiki Kaisha | Guide wire |
US9668674B2 (en) | 2015-03-03 | 2017-06-06 | Transseptal Solutions Ltd. | Measurement of appendage openings |
US9706982B2 (en) | 2015-03-03 | 2017-07-18 | Transseptal Solutions Ltd. | Treatment of appendage openings |
US10130369B2 (en) | 2015-03-24 | 2018-11-20 | Sentreheart, Inc. | Tissue ligation devices and methods therefor |
EP4282371A3 (en) | 2015-03-24 | 2024-03-06 | AtriCure, Inc. | Devices for left atrial appendage closure |
WO2016178171A1 (en) | 2015-05-07 | 2016-11-10 | The Medical Research Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center | Temporary interatrial shunts |
US10376673B2 (en) | 2015-06-19 | 2019-08-13 | Evalve, Inc. | Catheter guiding system and methods |
US10238494B2 (en) | 2015-06-29 | 2019-03-26 | Evalve, Inc. | Self-aligning radiopaque ring |
US10413408B2 (en) | 2015-08-06 | 2019-09-17 | Evalve, Inc. | Delivery catheter systems, methods, and devices |
WO2017042743A1 (en) | 2015-09-09 | 2017-03-16 | Baylis Medical Company Inc. | Epicardial access system & methods |
US10238495B2 (en) | 2015-10-09 | 2019-03-26 | Evalve, Inc. | Delivery catheter handle and methods of use |
US10398503B2 (en) | 2015-10-14 | 2019-09-03 | Transseptal Soulutions Ltd. | Fossa ovalis penetration |
US10463492B2 (en) | 2015-11-17 | 2019-11-05 | Edwards Lifesciences Corporation | Systems and devices for setting an anchor |
WO2017102941A1 (en) | 2015-12-15 | 2017-06-22 | Vivasure Medical Limited | Arteriotomy closure apparatus with slotted shoe for advantageous pressure distribution |
US11045218B2 (en) | 2016-01-21 | 2021-06-29 | University of Pittsburgh—of the Commonwealth System of Higher Education | Transatrial access for intracardiac therapy |
US10485579B2 (en) * | 2016-02-25 | 2019-11-26 | Indian Wells Medical, Inc. | Steerable endoluminal punch |
US11382654B2 (en) * | 2016-02-25 | 2022-07-12 | Indian Wells Medical, Inc. | Steerable endoluminal punch with cutting stylet |
US10729457B2 (en) * | 2016-02-25 | 2020-08-04 | Indian Wells Medical, Inc. | Steerable endoluminal punch with cutting stylet |
EP3419531B1 (en) | 2016-02-26 | 2024-04-03 | AtriCure, Inc. | Devices for left atrial appendage closure |
US10835394B2 (en) | 2016-05-31 | 2020-11-17 | V-Wave, Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US20170340460A1 (en) | 2016-05-31 | 2017-11-30 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
JP2019193681A (en) * | 2016-09-09 | 2019-11-07 | テルモ株式会社 | Medical device and treatment method |
US10737097B2 (en) * | 2016-09-16 | 2020-08-11 | Terrell M. Williams | Permanent his-bundle pacing device and method |
US11660121B2 (en) | 2016-10-18 | 2023-05-30 | East End Medical Llc | Transseptal insertion device |
US11426172B2 (en) | 2016-10-27 | 2022-08-30 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
EP3531926A2 (en) | 2016-10-27 | 2019-09-04 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
US20210275246A1 (en) * | 2016-11-01 | 2021-09-09 | Baylis Medical Company Inc. | Methods and Devices for Puncturing Tissue |
WO2018089689A1 (en) | 2016-11-11 | 2018-05-17 | Avenu Medical, Inc. | Systems and methods for percutaneous intravascular access and guidewire placement |
WO2018094029A1 (en) * | 2016-11-17 | 2018-05-24 | Boston Scientific Scimed Inc. | Hydraulic auto crossing balloon/catheter |
US20180140321A1 (en) | 2016-11-23 | 2018-05-24 | C. R. Bard, Inc. | Catheter With Retractable Sheath And Methods Thereof |
US10617854B2 (en) | 2016-12-09 | 2020-04-14 | Vascular Access Technologies, Inc. | Trans-jugular carotid artery access methods |
US11596726B2 (en) | 2016-12-17 | 2023-03-07 | C.R. Bard, Inc. | Ultrasound devices for removing clots from catheters and related methods |
US10758256B2 (en) | 2016-12-22 | 2020-09-01 | C. R. Bard, Inc. | Ultrasonic endovascular catheter |
CN108261216B (en) * | 2016-12-30 | 2021-03-19 | 先健科技(深圳)有限公司 | Conveying system of left auricle occluder |
US11654224B2 (en) | 2016-12-30 | 2023-05-23 | Vascular Access Technologies, Inc. | Methods and devices for percutaneous implantation of arterio-venous grafts |
US10582983B2 (en) | 2017-02-06 | 2020-03-10 | C. R. Bard, Inc. | Ultrasonic endovascular catheter with a controllable sheath |
WO2018158747A1 (en) | 2017-03-03 | 2018-09-07 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US11291807B2 (en) | 2017-03-03 | 2022-04-05 | V-Wave Ltd. | Asymmetric shunt for redistributing atrial blood volume |
CA3061230A1 (en) | 2017-04-28 | 2018-11-01 | Merit Medical Systems, Inc. | Introducer with partially annealed reinforcement element and related systems and methods |
WO2019035993A1 (en) * | 2017-08-16 | 2019-02-21 | Indian Wells Medical, Inc. | Steerable endoluminal punch with cutting stylet |
EP3459469A1 (en) | 2017-09-23 | 2019-03-27 | Universität Zürich | Medical occluder device |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
CA3082622C (en) | 2017-12-05 | 2021-02-02 | Wesley Robert PEDERSEN | Transseptal guide wire puncture system |
WO2019142152A1 (en) | 2018-01-20 | 2019-07-25 | V-Wave Ltd. | Devices and methods for providing passage between heart chambers |
US11458287B2 (en) | 2018-01-20 | 2022-10-04 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
US10898698B1 (en) | 2020-05-04 | 2021-01-26 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
USD876619S1 (en) * | 2018-03-06 | 2020-02-25 | Jasperate, Inc. | Hollow needle |
US10470797B1 (en) | 2018-07-17 | 2019-11-12 | SlipStream, LLC | Systems and methods for vascular access |
WO2020163507A1 (en) | 2019-02-08 | 2020-08-13 | Conformal Medical, Inc. | Devices and methods for excluding the left atrial appendage |
CN113692257A (en) * | 2019-03-20 | 2021-11-23 | 东区医疗有限公司 | Directional balloon transseptal insertion device for medical procedures |
US11253699B1 (en) | 2019-03-21 | 2022-02-22 | Terrell M. Williams | Cardiac pacing lead |
US11612385B2 (en) | 2019-04-03 | 2023-03-28 | V-Wave Ltd. | Systems and methods for delivering implantable devices across an atrial septum |
US11559669B2 (en) * | 2019-04-04 | 2023-01-24 | Medtronic, Inc. | Cannula delivery catheter and procedure method |
EP3972499A1 (en) | 2019-05-20 | 2022-03-30 | V-Wave Ltd. | Systems and methods for creating an interatrial shunt |
US11707321B2 (en) | 2019-06-11 | 2023-07-25 | East End Medical, Llc | Directional balloon transseptal insertion device for medical procedures with improved transseptal puncture system with puncture member balloon seal |
US11369355B2 (en) | 2019-06-17 | 2022-06-28 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
BR112022004429A2 (en) | 2019-09-13 | 2022-06-21 | Alleviant Medical Inc | Systems, devices and methods to form an anastomosis |
JP2022549717A (en) | 2019-09-26 | 2022-11-28 | ウニベルシタット チューリッヒ | left atrial appendage closure device |
MX2022004010A (en) | 2019-10-04 | 2022-05-19 | East End Medical Llc | Directional balloon transseptal insertion device for medical procedures with improved handle. |
US11759190B2 (en) | 2019-10-18 | 2023-09-19 | Boston Scientific Medical Device Limited | Lock for medical devices, and related systems and methods |
WO2021092576A1 (en) * | 2019-11-08 | 2021-05-14 | Amx Technologies, Llc | Methods and apparatus for heart valve leaflet modification |
US11801087B2 (en) | 2019-11-13 | 2023-10-31 | Boston Scientific Medical Device Limited | Apparatus and methods for puncturing tissue |
US11724070B2 (en) | 2019-12-19 | 2023-08-15 | Boston Scientific Medical Device Limited | Methods for determining a position of a first medical device with respect to a second medical device, and related systems and medical devices |
AU2021221979A1 (en) | 2020-02-18 | 2022-09-15 | East End Medical, Llc | Deflectable anchor balloon catheter for vascular procedures |
US11931098B2 (en) | 2020-02-19 | 2024-03-19 | Boston Scientific Medical Device Limited | System and method for carrying out a medical procedure |
US11819243B2 (en) | 2020-03-19 | 2023-11-21 | Boston Scientific Medical Device Limited | Medical sheath and related systems and methods |
US11826075B2 (en) | 2020-04-07 | 2023-11-28 | Boston Scientific Medical Device Limited | Elongated medical assembly |
US20210346081A1 (en) * | 2020-05-06 | 2021-11-11 | Evalve, Inc. | Devices and methods for leaflet cutting |
JP2023521165A (en) | 2020-06-17 | 2023-05-23 | ボストン サイエンティフィック メディカル デバイス リミテッド | electroanatomical mapping system |
US11938285B2 (en) | 2020-06-17 | 2024-03-26 | Boston Scientific Medical Device Limited | Stop-movement device for elongated medical assembly |
US11937796B2 (en) | 2020-06-18 | 2024-03-26 | Boston Scientific Medical Device Limited | Tissue-spreader assembly |
EP4168090A1 (en) * | 2020-06-19 | 2023-04-26 | Deinde Medical Corp. | Steerable catheters and related methods |
US11801369B2 (en) | 2020-08-25 | 2023-10-31 | Shifamed Holdings, Llc | Adjustable interatrial shunts and associated systems and methods |
US11857197B2 (en) | 2020-11-12 | 2024-01-02 | Shifamed Holdings, Llc | Adjustable implantable devices and associated methods |
US11234702B1 (en) | 2020-11-13 | 2022-02-01 | V-Wave Ltd. | Interatrial shunt having physiologic sensor |
US11812969B2 (en) | 2020-12-03 | 2023-11-14 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
US11446486B1 (en) | 2021-06-03 | 2022-09-20 | Gopi Dandamudi | Multielectrode medical lead |
WO2023199267A1 (en) | 2022-04-14 | 2023-10-19 | V-Wave Ltd. | Interatrial shunt with expanded neck region |
CN116687556B (en) * | 2023-08-02 | 2023-11-03 | 上海微创电生理医疗科技股份有限公司 | Puncture assembly, positioning method and three-dimensional display method |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5066285A (en) * | 1990-01-26 | 1991-11-19 | Cordis Corporation | Catheter introducer sheath made of expanded polytetrafluoroethylene |
US5312341A (en) * | 1992-08-14 | 1994-05-17 | Wayne State University | Retaining apparatus and procedure for transseptal catheterization |
US6066126A (en) * | 1997-12-18 | 2000-05-23 | Medtronic, Inc. | Precurved, dual curve cardiac introducer sheath |
US6245054B1 (en) * | 1998-11-09 | 2001-06-12 | Kristine B. Fuimaono | Guiding sheath exchange system |
US6266550B1 (en) * | 1998-01-16 | 2001-07-24 | Lumend, Inc. | Catheter apparatus for treating arterial occlusions |
US20010034514A1 (en) * | 2000-03-23 | 2001-10-25 | Cook Incorporated | Introducer sheath |
US20030040770A1 (en) * | 2001-08-23 | 2003-02-27 | Radisch Herbert R. | Segmented balloon catheter blade |
US6562049B1 (en) * | 2000-03-01 | 2003-05-13 | Cook Vascular Incorporated | Medical introducer apparatus |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3811449A (en) | 1972-03-08 | 1974-05-21 | Becton Dickinson Co | Dilating apparatus and method |
US4175545A (en) | 1977-03-10 | 1979-11-27 | Zafmedico Corp. | Method and apparatus for fiber-optic cardiovascular endoscopy |
FR2481917A1 (en) | 1979-08-14 | 1981-11-13 | Inst Nat Sante Rech Med | Arterial pulse measuring appts. - uses two IR signals reflected through artery to determine blood flow speed |
US4759348A (en) | 1981-09-28 | 1988-07-26 | Cawood Charles David | Endoscope assembly and surgical instrument for use therewith |
SU1297782A1 (en) | 1984-08-16 | 1987-03-23 | Пярнуская Межколхозная Свиноферма | Ultrasonic meter of thickness of fat interlayer |
US4718417A (en) | 1985-03-22 | 1988-01-12 | Massachusetts Institute Of Technology | Visible fluorescence spectral diagnostic for laser angiosurgery |
US4938220A (en) * | 1986-08-01 | 1990-07-03 | Advanced Cardiovascular Systems, Inc. | Catheter with split tip marker and method of manufacture |
JPH0824665B2 (en) | 1986-11-28 | 1996-03-13 | オリンパス光学工業株式会社 | Endoscope device |
FR2630223B1 (en) | 1988-04-14 | 1990-08-10 | Asulab Sa | ECHO TRACKER FOR ULTRASONIC MEASUREMENT OF THE POSITION OF A MOBILE WALL |
US4960412A (en) | 1988-04-15 | 1990-10-02 | Universal Medical Instrument Corp. | Catheter introducing system |
US4998972A (en) | 1988-04-28 | 1991-03-12 | Thomas J. Fogarty | Real time angioscopy imaging system |
US5499975A (en) | 1989-01-31 | 1996-03-19 | Cook Incorporated | Smooth transitioned dilator-sheath assembly and method |
US5820591A (en) | 1990-02-02 | 1998-10-13 | E. P. Technologies, Inc. | Assemblies for creating compound curves in distal catheter regions |
US5558093A (en) | 1990-05-18 | 1996-09-24 | Cardiovascular Imaging Systems, Inc. | Guidewire with imaging capability |
US5108413A (en) * | 1990-12-20 | 1992-04-28 | Moyers Robert E | Dilator for opening the lumen of a tubular organ |
US5180364A (en) * | 1991-07-03 | 1993-01-19 | Robert Ginsburg | Valved self-perfusing catheter guide |
US5772597A (en) | 1992-09-14 | 1998-06-30 | Sextant Medical Corporation | Surgical tool end effector |
JPH06190052A (en) * | 1992-09-18 | 1994-07-12 | Cordis Corp | Catheter insertion equipment of which fiber is reinforced |
US6285898B1 (en) | 1993-07-20 | 2001-09-04 | Biosense, Inc. | Cardiac electromechanics |
US5643231A (en) | 1993-08-13 | 1997-07-01 | Daig Corporation | Coronary sinus catheter |
US5628316A (en) | 1993-11-03 | 1997-05-13 | Swartz; John F. | Guiding introducer system for use in the right atrium |
US5575766A (en) | 1993-11-03 | 1996-11-19 | Daig Corporation | Process for the nonsurgical mapping and treatment of atrial arrhythmia using catheters guided by shaped guiding introducers |
US5722400A (en) | 1995-02-16 | 1998-03-03 | Daig Corporation | Guiding introducers for use in the treatment of left ventricular tachycardia |
US6203531B1 (en) | 1993-11-03 | 2001-03-20 | Daig Corporation | Guiding introducers for use in the treatment of accessory pathways around the mitral valve using a retrograde approach |
US5427119A (en) | 1993-11-03 | 1995-06-27 | Daig Corporation | Guiding introducer for right atrium |
US5497774A (en) | 1993-11-03 | 1996-03-12 | Daig Corporation | Guiding introducer for left atrium |
US5564440A (en) | 1993-11-03 | 1996-10-15 | Daig Corporation | Method for mopping and/or ablation of anomalous conduction pathways |
US5690611A (en) * | 1994-07-08 | 1997-11-25 | Daig Corporation | Process for the treatment of atrial arrhythima using a catheter guided by shaped giding introducers |
US6090084A (en) | 1994-07-08 | 2000-07-18 | Daig Corporation | Shaped guiding introducers for use with a catheter for the treatment of atrial arrhythmia |
US5558652A (en) | 1994-10-06 | 1996-09-24 | B. Braun Medical, Inc. | Introducer with radiopaque marked tip and method of manufacture therefor |
US5833673A (en) | 1994-11-02 | 1998-11-10 | Daig Corporation | Guiding introducer system for use in the treatment of left ventricular tachycardia |
US5814029A (en) | 1994-11-03 | 1998-09-29 | Daig Corporation | Guiding introducer system for use in ablation and mapping procedures in the left ventricle |
US6132438A (en) | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
US5772678A (en) * | 1995-10-20 | 1998-06-30 | Inlet Medical, Inc. | Retractable disposable tip reusable trocar obturator |
US5848969A (en) | 1996-10-28 | 1998-12-15 | Ep Technologies, Inc. | Systems and methods for visualizing interior tissue regions using expandable imaging structures |
US5722403A (en) * | 1996-10-28 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods using a porous electrode for ablating and visualizing interior tissue regions |
US5724975A (en) | 1996-12-12 | 1998-03-10 | Plc Medical Systems, Inc. | Ultrasonic detection system for transmyocardial revascularization |
US6004280A (en) | 1997-08-05 | 1999-12-21 | Cordis Corporation | Guiding sheath having three-dimensional distal end |
US6241678B1 (en) * | 1998-08-21 | 2001-06-05 | Aga Medical Corporation | Sizing catheter for measuring septal defects |
US6152144A (en) | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
US6231561B1 (en) | 1999-09-20 | 2001-05-15 | Appriva Medical, Inc. | Method and apparatus for closing a body lumen |
US6551303B1 (en) | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6650923B1 (en) | 2000-04-13 | 2003-11-18 | Ev3 Sunnyvale, Inc. | Method for accessing the left atrium of the heart by locating the fossa ovalis |
US7717899B2 (en) * | 2002-01-28 | 2010-05-18 | Cardiac Pacemakers, Inc. | Inner and outer telescoping catheter delivery system |
-
2002
- 2002-03-15 US US10/100,270 patent/US7056294B2/en not_active Expired - Lifetime
-
2003
- 2003-03-14 WO PCT/US2003/008044 patent/WO2003077733A2/en not_active Application Discontinuation
- 2003-03-14 AU AU2003225822A patent/AU2003225822A1/en not_active Abandoned
-
2005
- 2005-09-16 US US11/228,988 patent/US9131849B2/en not_active Expired - Lifetime
-
2015
- 2015-08-25 US US14/834,499 patent/US20150359563A1/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5066285A (en) * | 1990-01-26 | 1991-11-19 | Cordis Corporation | Catheter introducer sheath made of expanded polytetrafluoroethylene |
US5312341A (en) * | 1992-08-14 | 1994-05-17 | Wayne State University | Retaining apparatus and procedure for transseptal catheterization |
US6066126A (en) * | 1997-12-18 | 2000-05-23 | Medtronic, Inc. | Precurved, dual curve cardiac introducer sheath |
US6266550B1 (en) * | 1998-01-16 | 2001-07-24 | Lumend, Inc. | Catheter apparatus for treating arterial occlusions |
US6245054B1 (en) * | 1998-11-09 | 2001-06-12 | Kristine B. Fuimaono | Guiding sheath exchange system |
US6562049B1 (en) * | 2000-03-01 | 2003-05-13 | Cook Vascular Incorporated | Medical introducer apparatus |
US20010034514A1 (en) * | 2000-03-23 | 2001-10-25 | Cook Incorporated | Introducer sheath |
US20030040770A1 (en) * | 2001-08-23 | 2003-02-27 | Radisch Herbert R. | Segmented balloon catheter blade |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11179097B2 (en) | 2016-05-03 | 2021-11-23 | Texas Medical Center | Tactile sensing device for lumbar punctures |
US10383610B2 (en) | 2017-10-27 | 2019-08-20 | Intuitap Medical, Inc. | Tactile sensing and needle guidance device |
US11000311B2 (en) | 2017-10-27 | 2021-05-11 | Intuitap Medical, Inc. | Tactile sensing and needle guidance device |
Also Published As
Publication number | Publication date |
---|---|
WO2003077733A2 (en) | 2003-09-25 |
US20020169377A1 (en) | 2002-11-14 |
US20060009715A1 (en) | 2006-01-12 |
AU2003225822A8 (en) | 2003-09-29 |
US9131849B2 (en) | 2015-09-15 |
AU2003225822A1 (en) | 2003-09-29 |
WO2003077733A3 (en) | 2004-04-08 |
US7056294B2 (en) | 2006-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9131849B2 (en) | Method and apparatus for accessing the left atrial appendage | |
US6650923B1 (en) | Method for accessing the left atrium of the heart by locating the fossa ovalis | |
US11819228B2 (en) | Methods and systems for treating a pulmonary embolism | |
US8005529B2 (en) | Systems and methods for internal tissue penetration | |
US5941893A (en) | Apparatus for transluminally performing surgery | |
JPH03501089A (en) | balloon angioplasty catheter | |
JP2012513286A (en) | Ultrasound visualization endoscope access device | |
US11154325B2 (en) | Apparatus and method for septal punch | |
WO2023006073A1 (en) | Puncture instrument | |
US20220347394A1 (en) | Sheaths for needle delivery | |
US20230277208A1 (en) | Steerable Endoluminal Punch with Introducer and Guidewire | |
US20220280185A1 (en) | Catheter devices, needle assemblies, kits and methods | |
US20220160389A1 (en) | Endoluminal punch system | |
US20220249126A1 (en) | Apparatus and method for septal punch | |
CN217338745U (en) | Percutaneous intervention kit | |
US11660119B2 (en) | Catheter system for left heart access | |
US20230371982A1 (en) | Transseptal access device and method of use | |
JP2024502267A (en) | Apparatus and method for septal punch and delivery and maneuvering of therapeutic devices | |
JP2024508551A (en) | access catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |